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In various environmental conditions and at different stages of development, organisms turn 
some of their genes “on” and other genes - “off”. This process also enables cells that make up 
different organs in a multicellular organism to perform distinct functions, such as gas exchange 
by the lung and detoxification by the liver. In organisms other than bacteria and related 
microbes, DNA is located in a cellular compartment called the nucleus where it is wrapped 
around spheres made of proteins called histones. Specific chemical modifications on the 
histones recruit other factors that turn genes “on” or “off”.  
The aim of this project was to characterise the mechanism of gene regulation in Trypanosoma 
brucei, a single-celled parasite which causes sleeping sickness in Africa. The approach taken 
was to identify and add fluorescent tags to proteins potentially involved in adding, binding or 
removing chemical modifications on the histones. The tags were used to visualise under a 
microscope which candidate proteins are found in the nucleus and may therefore interact with 
trypanosome DNA to activate or repress genes. In subsequent experiments, antibodies 
against the tags were used to pull the nuclear proteins out of the cell and examine their 
associated DNA regions and protein interacting partners. 
Overall, 34 proteins were tagged and 8 of them were found to associate with DNA regions 
which regulate gene activation and repression. Additionally, two of these proteins were found 
to be part of the same protein complex. These results represent an initial stage of 








In eukaryotic nuclei, DNA is packaged into chromatin by association with histone proteins. 
Specific histone post-translational modifications result in the formation of transcriptionally 
active and silent chromatin domains. The aim of this project was to characterise chromatin 
organisation and assess the role of transcription regulation in Trypanosoma brucei, the 
causative agent of sleeping sickness in Africa. The approach taken was endogenous 
fluorescent tagging of putative readers, writers and erasers of histone modifications in T. 
brucei and subsequent use of the tags to localise the candidate proteins in the cell and to 
identify their genomic associations and protein interaction networks. Chromatin 
immunoprecipitation followed by sequencing showed that many of the nuclear proteins 
associate with RNAPII transcription start regions (TSRs). Whereas most proteins were 
enriched broadly over those regions, Chromo1 and SET27 displayed sharp overlapping peak 
profiles. Moreover, co-immunoprecipitation and mass spectrometry revealed that Chromo1 
and SET27 are likely part of the same complex together with four uncharacterised proteins 
and JBP2, an enzyme involved in the synthesis of the DNA modification base J. Overall, this 
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1.1 Trypanosoma brucei 
Trypanosoma brucei is a flagellated unicellular parasite that causes African trypanosomiasis, 
also known as sleeping sickness in humans and nagana in animals. It was discovered as the 
causative agent of cattle trypanosomiasis in the 19th century by Sir David Bruce (Bruce, 1895; 
Steverding, 2008), after whom the parasite is named.  
T. brucei belongs to the order Kinetoplastida together with other important pathogens, 
including Trypanosoma cruzi which causes Chagas disease in Latin America and Leishmania 
species causing leishmaniasis worldwide. Kinetoplastids were previously classified as 
members of the Excavata supergroup of eukaryotes (Walker et al., 2011) but this grouping 
was based on morphology and not monophyly. More recently, the excavate lineage was split 
into three, with kinetoplastids classified as part of the group of discobids (Figure 1.1) (Keeling 
and Burki, 2019). As illustrated in Figure 1.1, kinetoplastids are evolutionarily distant from well-
studied model organisms, such as budding and fission yeasts, and as a consequence many 
aspects of their biology differ from the common eukaryotic norm. For instance, a characteristic 
feature of these organisms is the presence of a single large mitochondrion in the cell where 
mitochondrial DNA (termed “kinetoplast DNA” or “kDNA”) is organised as a network of 
catenated maxi- and mini-circles, the former encoding rRNAs and respiratory chain proteins 
and the latter - guide RNAs for editing of mitochondrial protein transcripts (Cavalcanti and De 






Figure 1.1 Evolutionary tree of eukaryotes. Most commonly studied model organisms are 
within the Opisthokonta group whereas kinetoplastids are part of the evolutionarily distant 







1.1.1 African trypanosomiasis 
The three subspecies of T. brucei (T. b. gambiense, T. b. rhodesiense and T. b. brucei) are 
endemic to sub-Saharan Africa where they are transmitted to humans and animals by the 
tsetse fly (genus Glossina) (Brun et al., 2010). The people most vulnerable to infection live in 
rural areas where they rely primarily on agriculture, hunting and fishing for their income (WHO, 
2019). Thus, African trypanosomiasis is exerting not just a health burden but also economic 
hardship on affected communities. 
Only T. b. gambiense and T. b. rhodesiense are human-infective, the former being present in 
western and central Africa and the latter – in eastern and southern Africa (Figure 1.2). T. b. 
gambiense causes a chronic form of the disease and is responsible for 98% of the sleeping 
sickness cases whereas T. b. rhodesiense causes an acute infection that accounts for 2% of 
the cases (WHO, 2019). Sleeping sickness progresses in two stages with characteristic 
symptoms and localisation of parasites in the body. In the early form of the disease, known as 
the haemolymphatic stage, trypanosomes multiply in the blood, lymph, interstitial spaces as 
well as the adipose tissue (Trindade et al., 2016) and the skin (Caljon et al., 2016; Capewell 
et al., 2016). The symptoms at this stage include headache, pruritus and bouts of fever 
(Büscher et al., 2017). In the second (meningoencephalitic or neurological) stage of sleeping 
sickness, trypanosomes cross the blood-brain barrier and invade the central nervous system 
(CNS) which gives rise to neurological symptoms including confusion, poor coordination and 





Figure 1.2 Distribution of sleeping sickness cases caused by T. b. gambiense and T. b. 
rhodesiense during the 2010-2014 period. Figure from Büscher et al. (2017). 
 
Without treatment, sleeping sickness is almost always fatal, thus early diagnosis of the disease 
is paramount. Ideally, trypanosome infections should be confirmed microscopically in a blood 
smear, lymph node aspirate or, during the second stage of the disease, cerebrospinal fluid. 
This applies particularly to T. b. rhodesiense infections because of the high level of 
parasitaemia caused by this subspecies (Kennedy, 2019). In the case of T. b. gambiense, the 
parasitaemia is cyclical and thus direct observation of a trypanosome infection in a patient is 





Distinguishing between the early and late form of the disease is also highly important because 
of the toxic nature of drugs used to treat the neurological stage. Currently, first-line treatment 
for early stage T. b. gambiense infection is intramuscular or intravenous administration of 
pentamidine which disrupts mitochondrial function of the parasite (Lanteri et al., 2008). Early 
stage T. b. rhodesiense infection is treated with intravenous administration of suramin which 
may act by inhibiting glycolysis (Morgan et al., 2011) on which the parasites are entirely 
dependent for energy in the mammalian bloodstream (Priest and Hajduk, 1994). While both 
pentamidine and suramin are generally well tolerated by patients, the drugs currently in use 
for late stage sleeping sickness are highly toxic.  Melarsoprol is an arsenic drug used to 
combat CNS infection with both T. b. rhodesiense and T. b. gambiense and causes post-
treatment reactive encephalopathy in about 10% of cases, half of which are fatal (Brun et al., 
2010). Second stage T. b. gambiense infection is also treated with nifurtimox–eflornithine 
combination therapy (NECT), with bone marrow toxicity and the potential for septicaemia 
being the major adverse effects of this treatment (Field et al., 2017; Kennedy, 2013). 
Melarsoprol may act by inhibiting mitosis (Thomas et al., 2018), nifurtimox – through oxidative 
stress (Denise and Barrett, 2001) or the production of cytotoxic nitrile metabolites (Hall et al., 
2011) and eflornithine – by inhibiting ornithine decarboxylase (Bacchi et al., 1980). All of the 
treatments discussed here have been in use for more than a decade (some for over 50 years) 
and there is a growing concern about trypanosome drug resistance. In particular, resistance 
to both pentamidine and melarsopol caused by mutations in the transporters involved in their 
uptake has been documented (Baker et al., 2013). New drugs are currently being developed, 
including the orally administered fexinidazole which was shown to be effective in 91% of 
patients with a late stage sleeping sickness caused by T. b. gambiense in a randomised trial 
conducted in the Democratic Republic of Congo (Mesu et al., 2018).  Fexinidazole acts by 
inhibiting DNA synthesis and was recently approved for treatment of both early and late stage 
sleeping sickness (Deeks, 2019). 
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Disease prevention is done predominantly via vector population control as vaccination is 
deemed unfeasible due to the parasite’s ability to change its surface antigen presentation (see 
section 1.1.3). 
Currently, the prevalence of sleeping sickness is declining (Figure 1.3), with only 1446 new 
cases reported in 2017, and the disease is targeted by the World Health Organisation (WHO) 
for elimination by 2020 (WHO, 2019). This may be problematic for T. b. rhodesiense as it 




Figure 1.3 Sleeping sickness cases caused by T. b. rhodesiense and T. b. gambiense 
for the period 2000-2014 with projected cases for the period 2015-2020. HAT – human 
African trypanosomiasis. Figure from Franco et al. (2017). 
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Animal African trypanosomiasis, also known as nagana, is caused predominantly by 
Trypanosoma congolense and Trypanosoma vivax, with T. brucei accounting for a minor 
proportion of cases (Morrison et al., 2016).  It is characterised by anaemia, emaciation, 
infertility and loss of productivity (Giordani et al., 2016). While human sleeping sickness is on 
track to be eliminated in the near future, nagana remains one of the most significant livestock 
infections in sub-Saharan Africa, hindering agricultural development in rural areas (Morrison 
et al., 2016). 
Humans and some primates have innate immunity against several trypanosome species, 
including T. b. brucei, owing to trypanosome lytic factors (TLFs) present in their serum. TLFs 
are high-density lipoprotein particles containing apolipoprotein L1 (ApoL1), which kills the 
parasites by forming ionic pores in their endolysosomal membranes (Perez-Morga, 2005; 
Vanhamme et al., 2003). ApoL1 is internalised primarily via the trypanosome haptoglobin-
haemoglobin receptor (TbHpHbR) (Vanhollebeke et al., 2008). The initial association with 
endosomes is critical for ApoL1 function because membrane insertion of this protein is 
dependent on acidic pH (Hager, 1994; Lecordier et al., 2009). T. b. rhodesiense and T. b 
gambiense have evolved different mechanisms for escaping the trypanolytic action of ApoL1. 
T. b. rhodesiense expresses a serum resistance-associated (SRA) protein which is targeted 
to the endolysosomal system of the parasite where it neutralizes ApoL1 via strong interaction 
with the C-terminal helix of ApoL1 (Lecordier et al., 2009; Van Xong et al., 1998; Vanhamme 
et al., 2003). The T. b. gambiense subspecies is divided into two genetically distinct groups 
which differ in their resistance mechanisms to human serum. Group 1 resistance is due to an 
amino acid substitution in TbHpHbR which reduces ApoL1 uptake (Dejesus et al., 2013). 
Additionally, group 1 resistance is conferred by T. b. gambiense-specific glycoprotein (TgsGP) 
which induces stiffening of endolysosomal membranes (Uzureau et al., 2013), presumably 
inhibiting ApoL1 insertion. Group 2 T. b. gambiense exhibit variable resistance to human 
serum. They have been shown to internalize TLF and therefore their resistance could be due 
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to neutralisation or countering the effects of ApoL1 as opposed to impaired uptake (Capewell 
et al., 2011). 
1.1.2 Trypanosome cell biology 
The trypanosome cell (Figure 1.4) is spindle-shaped with a single flagellum emerging from an 
invagination of the cell membrane termed the flagellar pocket which is located in the posterior 
end of the cell and is the only known site of exo- and endocytosis (Overath and Engstler, 
2004). The flagellum is attached lengthwise until the anterior end of the parasite and extends 
beyond the cell body. Cell morphology is maintained by a subpellicular array of microtubules, 
oriented with their plus ends towards the posterior and with their minus ends towards the 
anterior of the cell (Robinson, 1995).  Many trypanosome organelles are highly positioned and 
single-copy: the nucleus, mitochondrion (including the kinetoplast), Golgi, terminal lysosome 






Figure 1.4 T. brucei cell architecture. The positions of major organelles are highlighted. The 
flagellar pocket and the kinetoplast are at the posterior end whereas the flagellum extends 







In laboratory culture, T. brucei undergoes propulsive movement interspersed with periods of 
tumbling or irregular movement (Langousis and Hill, 2014). When the culture media viscosity 
was designed to match that of blood, the proportion of trypanosomes undergoing propulsive 
movement increased, demonstrating that the movement of bloodstream form T. brucei is fine 
tuned to its host environment (Heddergott et al., 2012). In the fly host trypanosomes exhibit 
social motility, a form of en masse movement in response to a particular stimulus. 
Trypanosome social motility depends on flagellar cAMP signalling which is in turn required for 
progression of T. brucei through the fly host tissues and completion of its life cycle (Shaw et 
al., 2019). 
The basal body of the flagellum is linked directly to the kinetoplast genome via the tripartite 
attachment complex (TAC) which traverses the double mitochondrial membrane (Ogbadoyi et 
al., 2003). This physical link between the basal body and the kinetoplast provides a 
mechanistic explanation for their coordinate replication and division (Robinson and Gull, 
1991). Duplication of the basal body and nucleation of a daughter flagellum are the earliest 
detectable cytological events during the trypanosome cell cycle (Woodward and Gull, 1990). 
T. brucei undergoes a closed mitosis, with the mitotic spindle forming inside the nucleus 
(Ogbadoyi et al., 2000). No appreciable condensation of chromosomes has been observed 
during trypanosome cell division. The kinetoplast replicates before the nuclear genome and is 
segregated together with the basal body prior to the onset of mitosis (Sherwin et al., 1989). 
This allows the stages of the cell cycle to be distinguished (microscopically or via FACS 
sorting) by DNA staining (Figure 1.5). In G1 phase, cells have one kinetoplast and one nucleus 
which is termed 1K1N configuration. As the cell cycle progresses, the basal body duplicates, 
driving the segregation of the kinetoplast. The kinetoplast starts dividing (has elongated 
morphology) during the nuclear S phase. In G2, the kinetoplast has divided and the cells are 
in a 2K1N configuration. Finally, post-mitotic cells have two kinetoplasts and two nuclei 




Figure 1.5 T. brucei cell cycle. (a) G1 cells have a single kinetoplast and nucleus (1K1N). 
(b) Coordinate division of the basal body and the kinetoplast. (c) The kinetoplast has divided 
during the nuclear S phase (2K1N). (d) The nuclear genome enters mitosis. (e) Post-mitotic 
cells have two kinetoplasts and two nuclei (2K2N). (f) Cytokinesis proceeds via cytokinesis 
furrow ingression between the old and new flagellum. (g) Both daughter cells have inherited a 
single kinetoplast, nucleus and flagellum. Figure from Akiyoshi and Gull (2013). 
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1.1.3 Life cycle  
During its life cycle, T. brucei alternates between a mammalian host and the tsetse fly vector 
(Figure 1.6). The within and between host transitions are characterised by specific 
morphological and surface proteome changes as well as metabolic adaptations that allow the 
parasites to survive in the varying host environments they encounter.   
There are two morphotypes during the developmental cycle of the parasite – a trypomastigote 
and an epimastigote form.  T. brucei spends the majority of its life cycle as a trypomastigote 
which is characterised by posterior localisation of the basal body and the kinetoplast. The 
latter are more central in the cell and anterior to the nucleus in the epimastigote form 
(Langousis and Hill, 2014).  
The parasite is extracellular at all developmental stages. The long slender form trypanosomes 
proliferate in the mammalian bloodstream until they reach a critical density when they 
differentiate to the division-arrested short stumpy form. This process is triggered by the 
accumulation of the stumpy induction factor (SIF), an extracellular signal internalised via an 
oligopeptide transporter related to G protein-coupled receptors (Rojas et al., 2019). 
Accumulation of non-dividing stumpy forms limits the parasite burden and prolongs host 
survival as well as adapting the parasite for transmission to the tsetse (MacGregor et al., 
2012). Recently, it has been shown that the skin and adipose tissue are additional reservoirs 
of T. brucei in the mammalian host (Caljon et al., 2016; Capewell et al., 2016; Trindade et al., 
2016). Adipose tissue forms (ATFs) were found to be transcriptionally and metabolically 
distinct from bloodstream form (BF) parasites but were also capable of differentiating to the 




Stumpy cells are ingested by the tsetse during a blood meal and, once in the fly midgut, they 
sense a drop in temperature and the presence of cis-aconitate and citrate, which triggers their 
differentiation to the proliferating procyclic form (PF) (Engstler, 2004). Proteases in the fly 
midgut may also contribute to the production of the differentiation signal. Proteins associated 
with differentiation (PAD) are carboxylate transporter protein family members required for the 
response to cis-aconitate and citrate (Dean et al., 2009). PAD2 expression is upregulated 
upon the decrease in temperature in the fly whereas PAD1 is a stumpy-specific surface 
protein.  
Procyclic cells migrate from the tsetse midgut to the fly proventriculus where they undergo an 
asymmetric cell division which generates one short and one long epimastigote form. Short 
epimastigotes attach to the salivary gland epithelium of the fly and divide symmetrically until 
eventually an asymmetric division gives rise to the metacyclic form which detaches from the 
epithelium and can infect the mammalian host, thus completing the life cycle of T. brucei 
(Rotureau et al., 2012). The fly salivary glands are also the site of haploid gamete production 
via meiosis and their subsequent fusion facilitated by flagellar interactions (Peacock et al., 
2014). 
Laboratory cell lines of bloodstream form trypanosomes can be pleomorphic or monomorphic 
depending on their differentiation capacity. Pleomorphic cells can differentiate to the stumpy 






Figure 1.6 Life cycle of T. brucei. Major parasite developmental stages are depicted. 
Dividing forms are marked with circular arrows. Figure from Langousis and Hill (2014). 
 
In the mammalian host, T. brucei is covered by a dense surface coat made of ~10 million 
copies of a glycosylphosphatidylinositol (GPI)-anchored variant surface glycoprotein (VSG). 
VSGs are homodimers, with each monomer consisting of a variable N-terminal domain which 
is membrane-distal and exposed, and a conserved C-terminal domain which links the VSG to 
the plasma membrane (Carrington et al., 1991; Schwede et al., 2011). The VSG coat protects 
trypanosomes by shielding invariant surface antigens from the mammalian immune system 




antigenic variation, helps T. brucei evade the host immune response and maintain a chronic 
infection (Vickerman, 1978). Normally, only a single VSG is expressed from an archive 
consisting of ~2000 genes (Horn, 2014). T. brucei periodically switches to express a new VSG 
to which no antibodies have been produced, leading to waves of parasitaemia (Figure 1.7). 
Up to ~100 different VSG variants can be present in the population at peak parasitaemia 
(Mugnier et al., 2015). VSG expression is discussed in more detail in section 1.3.2. The VSG 
coat is exceptionally fluid due to attachment via a GPI anchor as opposed to a transmembrane 
domain. This fluidity facilitates coat recycling through the endocytic system which is important 
for rapid VSG turnover during switching as well as clearing of surface-bound antibodies 
present at low concentrations (Engstler et al., 2007; Natesan et al., 2011; Pal et al., 2003; 
Seyfang et al., 1990). 
 
 
Figure 1.7 T. brucei antigenic variation leads to relapsing parasitaemia. During a 
trypanosome infection, some parasites switch to express new VSGs (depicted by the different 
colours) that are not immediately recognised by the immune system. Antibodies are depicted 
as Y-shaped structures. 
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In the fly midgut, procyclic cells have a different glycoprotein surface coat made of EP 
(containing Glu-Pro repeats) and GPEET (containing Gly-Pro-Glu-Glu-Thr repeats) procyclins 
(Roditi and Liniger, 2002). Later during the tsetse infection, T. brucei loses the GPEET 
procyclins (Vassella et al., 2000) whereas the EP coat persists until the epimastigote stage in 
the salivary glands when the parasites are covered by a brucei alanine-rich protein (BARP) 
(Urwyler et al., 2007). Upon differentiation of the epimastigotes to the metacyclic form, the 
BARP coat is replaced by VSG. 
Apart from changes in the surface coat, trypanosomes undergo significant metabolic 
reprogramming during their developmental cycle. In the mammalian bloodstream, T. brucei 
generates ATP exclusively via glycolysis (Haanstra et al., 2011), with ATFs having 
upregulated expression of enzymes involved in fatty acid oxidation (Trindade et al., 2016). 
Kinetoplastids and their sister group Diplonemida possess unique peroxisome-like organelles 
called glycosomes which sequester most of the glycolytic enzymes (Allmann and Bringaud, 
2017; Opperdoes and Borst, 1977). In the fly, glucose is replaced by proline as the main 
energy source (Bursell, 1963).  Proline is actively imported (L'Hostis et al., 1993) and 
metabolised in the parasite mitochondrion via oxidative phosphorylation (van Hellemond et 
al., 2005). Consequently, procyclic cells possess a more active and elaborate mitochondrion 
than slender bloodstream forms (Vickerman, 1985). In preparation for transition from the 
mammalian to the fly host, stumpy forms activate their mitochondrion, as evidenced by the 
upregulation of mitochondrial respiration genes (Brown et al., 1973; Michelotti and Hajduk, 
1987; Van Grinsven et al., 2009) and the expansion and elaboration of the mitochondrial 






1.1.4 Genome organisation 
The genome of T. brucei is ~35 Mb and is organized into 11 megabase (1-6 Mb), 1-5 
intermediate (200-900 kb) and about 100 minichromosomes (50-150 kb) (El-Sayed et al., 
2000) (Figure 1.8). The megabase chromosomes are diploid whereas the intermediate and 
minichromosomes are probably haploid (Ersfeld, 2011). The chromosomes are linear and end 
with typical telomeric repeats (TTAGGG). Trypanosome telomere length increases by ~ 8 bp 
per cell division owing to constitutive telomerase activity (Horn et al., 2000). This increase is 
combined with an occasional loss of large portion of the telomeric repeats (Bernards et al., 
1983; Pays et al., 1983). Thus, telomere length can differ significantly between individual 
parasites in the population (3-20 kb in the Lister 427 strain) (Dreesen and Cross, 2008). A 
significant proportion of the trypanosome genome (~15%) is dedicated to providing a large 
reservoir of VSG genes. The diploid megabase chromosomes harbour about 9000 genes, 
including housekeeping genes as well as a major proportion of the ~2000 VSGs, which are 
located in long subtelomeric arrays (Berriman et al., 2005). A smaller subset of VSG genes 
and VSG gene fragments is also found on the intermediate and minichromosomes.  
The vast majority of T. brucei genes are intronless, with the exception of a poly(A) polymerase 
and a DNA/RNA helicase (Jaé et al., 2010; Mair et al., 2000; Siegel et al., 2010). Most genes 
are transcribed in polycistronic units, with some units containing more than 100 genes. The 
housekeeping genes are predicted to be expressed from ~150 transcription units, with a mean 
of 153 kb and 55 ORFs (Daniels et al., 2010).  The single active VSG is transcribed from one 
of several specialised subtelomeric regions termed VSG expression sites (ESs) found on the 
megabase and intermediate chromosomes. Bloodstream parasites express VSG from one of 
~15 polycistronic bloodstream expression sites (BESs) whereas metacyclic forms in the fly 
salivary glands express VSG from one of 5 monocistronic metacyclic expression sites (MESs) 
(Alarcon et al., 1994; Graham and Barry, 1995; Hertz-Fowler et al., 2008; Kolev et al., 2017). 
Trypanosome gene expression is discussed in more detail in section 1.3.  
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T. brucei centromeres have been mapped by topoisomerase II activity to AT-rich repetitive 
regions stretching over several kb on the megabase chromosomes (Obado et al., 2007). 
These repeats are ~147 bp long, and are thus termed chromosome internal repeats 147 
(CIR147) (Patrick et al., 2009). They are usually flanked by rRNA genes and retrotransposons. 
Eukaryotic centromeres typically contain CENP-A, a histone H3 variant which specifies the 
site of kinetochore assembly (Buscaino et al., 2010; Earnshaw and Rothfield, 1985). 
Kinetoplastids lack CENP-A and the ~50 kinetochore proteins conserved from yeast to human, 
and instead possess a set of about 20 unconventional kinetoplastid kinetochore proteins 
(KKTs) that do not have a homolog in other eukaryotes (Akiyoshi and Gull, 2014). The 
attachments of megabase chromosomes to the spindle are mediated by KKT4 (Llauró et al., 
2018). 
No site-specific accumulation of topoisomerase II activity has been detected on the 
intermediate and minichromosomes which may not possess canonical centromeres. 
Additionally, the number of spindle microtubules was found to be insufficient for one 
microtubule to attach to each chromosome (Wickstead et al., 2004). Intermediate 
chromosomes are composed of a non-repetitive core and 177 bp subtelomeric repeats and 
contain VSG ESs (Figure 1.8), suggesting these chromosomes may have originated via 
subtelomeric breakage of megabase chromosomes (Berriman et al., 2002). Minichromosomes 
have a large palindromic core made of 177 bp repeats with a single inversion point in the 
centre and harbour VSG genes in their subtelomeric regions (Figure 1.8). They are partitioned 
faithfully during cell division via lateral attachments to the spindle microtubules prior to the 
segregation of the megabase chromosomes (Alsford et al., 2001; Ersfeld and Gull, 1997). 
Surprisingly, cohesin, which is normally required for keeping the sister chromatids together 
during cell division,  was found to be dispensable during minichromosome segregation (Bessat 





Figure 1.8 Trypanosome chromosome organisation. From top to bottom: megabase, 
intermediate and minichromosomes (not drawn to scale). All chromosome types end with 
canonical telomeric repeats. Centromeric CIR147 repeats have been found only on the 
megabase chromosomes. VSGs are transcribed from subtelomeric ESs (BESs in the 
bloodstream form and MESs in the metacyclic form) on the megabase and intermediate 
chromosomes. Most of the silent VSG genes are located in subtelomeric arrays on the 
megabase chromosomes.  177 bp repeats are found in the subtelomeres of intermediate and 









In eukaryotic nuclei, DNA is packaged into chromatin by association with histone proteins (Li 
and Reinberg, 2011). This reduces significantly the length of DNA and allows eukaryotic 
genomes to fit into relatively small nuclei.  Additionally, chromatin regulates gene expression, 
minimizes DNA damage and genomic instability, and facilitates chromosome segregation 
during cell division.  
The fundamental unit of chromatin is the nucleosome which consists of ~147 bp of DNA 
wrapped around a histone octamer composed of one histone H3/H4 tetramer and two histone 
H2A/H2B dimers (Kornberg, 1974; Luger et al., 1997). One or more of these core histones 
can be substituted for a histone variant which gives nucleosomes new functional properties 
(Weber and Henikoff, 2014). Histone H1 binds to linker DNA between neighbouring 
nucleosomes and facilitates higher order compaction of chromatin.  
1.2.1 Active and silent chromatin  
The two main states of chromatin are euchromatin which is found mainly in the nuclear interior 
and heterochromatin which is located predominantly in the nuclear periphery. An exception 
from this architecture are the inverted nuclei found in the rod cells of the retina in some 
nocturnal mammals (Solovei et al., 2009). In these inverted nuclei, heterochromatin is found 
in the nuclear centre whereas euchromatin is localised in the nuclear periphery. Euchromatin 
and heterochromatin were initially distinguished microscopically by Emil Heitz in 1928 as 
differentially stained chromosomal regions during the cell cycle (Passarge, 1979). 
Euchromatin is more open and accessible to the transcription machinery whereas 
heterochromatin is highly condensed and inaccessible (Allshire and Madhani, 2018). 
Heterochromatic regions can be further subdivided into constitutive heterochromatin which is 
always repressive and facultative heterochromatin which can decondense when triggered by 
specific environmental and developmental stimuli. Constitutive heterochromatin is found at 
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centromeres, telomeres and transposable elements, and is involved in the faithful segregation 
of chromosomes during cell division as well as the suppression of transposons. Facultative 
heterochromatin is found, for example, on the inactive X chromosome of female mammals.  
Chromatin organisation into transcriptionally active and repressive domains depends on the 
presence of histone variants, DNA methylation and post-translational modifications (PTMs) of 
the histones. For instance, the H2AZ histone variant is thought to destabilise nucleosomes 
near transcription start sites (TSSs), thus facilitating the opening of chromatin and transcription 
initiation (Henikoff and Smith, 2015). Conversely, methylation of cytosine residues in DNA 
represses gene expression (Jaenisch and Bird, 2003). The effect of histone PTMs is discussed 
in more detail in section 1.2.2.  
Additionally, RNA interference (RNAi) is known to provide a link between transcriptional and 
post-transcriptional silencing. In many eukaryotes, siRNA producing loci, such as 
retrotransposable elements, recruit the RNAi machinery which stimulates the formation of 
heterochromatin leading to transcriptional silencing of these regions (Allshire and Madhani, 
2018). 
1.2.2 Readers, writers and erasers of histone modifications 
Histones are globular proteins with unstructured N-terminal tails protruding from the 
nucleosome core. The tails are rich in basic amino acids and are subject to various post-
translational modifications (Table 1.1) which are deposited by “writers”, interpreted by 
“readers” and removed by ”erasers” (Torres and Fujimori, 2015) (Figure 1.9). The globular C-
terminal domains of histones can also be post-translationally modified. Reader, writer and 
eraser activities may be contained within the same protein or protein complex which could, for 
example, aid heterochromatin spreading (reader + writer activity).  This project focused on 
acetylation and methylation which are the best characterised histone PTMs. 
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Table 1.1 Overview of histone post-translational modifications 
Some PTMs, such as phosphorylation, can occur only once per amino acid residue whereas 
other PTMs, such as methylation, can occur mutiple times per amino acid residue. Table 




Figure 1.9 Histone writers, readers and erasers. Histone tails protrude from the 
nucleosome core and can be modified by writer enzymes. The resulting modifications recruit 
readers which mediate the cellular response. The removal of the histone modifications is 




Histone acetyl transferases (HATs) are a diverse class of enzymes that use acetyl-CoA as a 
substrate to acetylate lysine residues of the histone tails (Lee and Workman, 2007). The acetyl 
groups neutralize the positive charges of the histones, thus decreasing the nucleosome affinity 
for the negatively charged DNA and causing chromatin decompaction (Hong et al., 1993). 
Bromo-domain proteins bind to acetylated histones and therefore are typically present in active 
chromatin. Acetyl marks are removed by several classes of histone deacetylases (HDACs) 
and silent information regulator 2 (Sir2) proteins, or sirtuins, leading to tighter binding between 
DNA and histones and suppression of gene expression (Haberland et al., 2009; Schwer and 
Verdin, 2008). 
Lysine residues can also be mono-, di- or tri-methylated by lysine methyltransferases (KMTs) 
which use S-adenosyl methionine as a methyl group donor. Most KMTs contain SET 
(suppressor of variegation 3-9, enhancer of zeste and trithorax) catalytic domains, with the 
exception of DOT1 which methylates H3K79. Depending on the residue that is modified, 
histone methylation can result in the activation or repression of gene expression. For instance, 
tri-methylation of K4 of histone H3 (H3K4me3) is a hallmark of active transcription (Santos-
Rosa et al., 2002). Methylation of H3K36 and H3K79 have also been associated with actively 
transcribed genomic regions. H3K36me2/me3 residues recruit an HDAC complex which 
removes acetyl groups from histones and promotes nucleosome reassembly behind RNA Pol 
II (RNAPII) (Smolle et al., 2013). The mechanism of action of H3K79 methylation is less well 
understood (Farooq et al., 2016). H3K9, H3K27 and H4K20 methylations are normally found 
in silent chromatin regions. Di- and tri-methylated H3K9 residues recruit heterochromatin 
protein-1 (HP1), leading to the formation of constitutive heterochromatin (Allshire and 
Madhani, 2018) whereas methylation of H3K27 is found in facultative chromatin (Jamieson et 
al., 2016). Although, in many eukaryotes H3K9 methylation specifies heterochromatin 
formation, there are known exceptions. For example, budding yeast heterochromatin is formed 
upon histone deacetylation by sirtuin proteins (Kueng et al., 2013). Chromo-domains, 
malignant brain tumour (MBT) and plant homeodomain (PHD) fingers recognize methylated 
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lysines whereas Tudor-domains bind to methylated lysines and arginines (Taverna et al., 
2007).  Lysine demethylases fall into two categories: Jumonji (Jmj) family and LSD1 homologs 
(Cloos et al., 2008). 
Individual histone PTMs do not act in isolation but rather function in the context of other histone 
modifications present on the same or on neighbouring nucleosomes. Effector proteins or 
protein complexes often contain multiple binding domains for the same or different histone 
marks (Ruthenburg et al., 2007). Significantly, bivalent nucleosomes have been described 
which contain both active and repressive marks (e.g. H3K4me3 and H3K27me3). These are 
found mainly at developmentally regulated genes, keeping the latter silent but poised for 
activation (Bernstein et al., 2006; Fisher and Fisher, 2011; Mikkelsen et al., 2007). All of these 
factors contribute to the formation of a complex chromatin landscape that, together with post-
transcriptional mechanisms, can account for the elaborate gene expression patterns in 
eukaryotes. 
1.2.3 Specifics of trypanosome chromatin 
Similarly to other eukaryotes, electron microscopy of nuclei from T. brucei has revealed 
electron-dense “heterochromatic” regions close to the nuclear periphery and electron-lucent 
“euchromatic” regions in the nuclear interior and in the vicinity of nuclear pores (Daniels et al., 
2010; Ogbadoyi et al., 2000). However, it is unclear whether these microscopically distinct 
regions correspond functionally to transcriptionally active and silent genomic regions. 
Trypanosomes have a high gene density and most of the megabase chromosomes are 
considered to be transcriptionally active, with the exception of the silent VSG arrays. On the 
other hand, the minichromosomes are highly repetitive and contain only silent VSG genes, so 
are likely to be heterochromatic. VSG ESs can be in an active or repressed state and might 
therefore represent examples of trypanosome facultative heterochromatin.  
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Although histones are some of the most well-conserved proteins among eukaryotes, 
trypanosome histones differ significantly from the common eukaryotic norm (Mandava et al., 
2007; Thatcher and Gorovsky, 1994) (Figure 1.10). Notably, T. brucei lacks the H3K9 residue 
and therefore employs a distinct mechanism for heterochromatin formation. 
 A survey of trypanosome histone modifications using Edman degradation and mass 
spectrometry revealed an absence of some well-conserved PTMs and a presence of 
trypanosome-specific marks (Janzen et al., 2006a; Mandava et al., 2007). The C-terminal 
region of H2A is heavily acetylated in T. brucei. The function of these acetyl marks is unclear, 
but they may contribute to a more open chromatin structure. H2B is the least conserved 
trypanosome histone and some T. brucei-specific marks have been detected on it: A1 
methylation and K4, K12 and K16 acetylation. Additionally, the trypanosome H2B lack K120, 
a conserved lysine residue, ubiquitination of which in many organisms is required for H3K4 
and H3K79 methylation (Briggs et al., 2002; Sun and Allis, 2002). A few residues of the N-
terminal region of histone H3 are conserved in T. brucei, including K4 which, as in other 
eukaryotes, can be methylated and the H3K4me3 mark has been found at active RNAPII 
TSRs (Wright et al., 2010). One of the best characterized trypanosome modifications is 
methylation of H3K76 (the homolog of H3K79) by DOT1A and DOT1B which are responsible 
for di- and tri-methylation of this residue, respectively (Janzen et al., 2006b). In T. brucei, 
H3K76 methylation is involved in the regulation of the cell cycle and VSG switching (Figueiredo 
et al., 2008; Janzen et al., 2006b). H4 is the most conserved T. brucei histone. Acetylation of 
H4K10 (homolog of H4K12) was found to be enriched at RNAPII TSRs and is potentially 
required for transcription initiation (Siegel et al., 2009). A similar set of histone modifications 
was identified more recently in Trypanosoma cruzi (De Jesus et al., 2016). 
Apart from the core histones, trypanosomes have four histone variants – H2AZ and H2BV 
which are found near RNAPII transcription start regions (TSRs), and H3V and H4V which are 
found at RNAPII transcription termination regions (TTRs) (Siegel et al., 2009).  
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The trypanosome linker histone H1 lacks the central globular domain thought to mediate 
nucleosome interactions and instead consists of a single domain corresponding to the C-
terminal portion of H1 in other eukaryotes (Povelones et al., 2012). Knock down experiments 
showed that in T. brucei H1 is required for chromatin compaction and VSG silencing 
(Povelones et al., 2012). 
 
 
Figure 1.10 Alignment of the N-terminal tails of core histones in T. brucei and some 
Opisthokonts. Identical residues are shaded. The sequence ruler is included only when the 
sequences are highly concordant and is based on the H. sapiens positions. Figure modified 
from Mandava et al. (2007). 
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There are two classes of trypanosome histone acetyltransferases: the MYST family and two 
homologs of the human ELP3 (ELP3a and ELP3b) (Figueiredo et al., 2009; Kawahara et al., 
2008; Siegel et al., 2007). The trypanosome genome also encodes class I and class II HDACs 
as well as SIR2-related deacetylases (Alsford et al., 2007; García-Salcedo et al., 2003; Ingram 
and Horn, 2002). T. brucei has ~30 SET-domain putative lysine methyltransferases as well as 
two DOT1 homologs (DOT1A and DOT1B). Lysine methyl marks are removed by JmjC 
demethylases whereas LSD1 homologs have not been found (Figueiredo et al., 2009). 
Additionally, T. brucei has several candidate arginine methyltransferases. Putative readers of 
histone PTMs in T. brucei include proteins containing Bromo-, Chromo-, PHD finger and Tudor 
domains. 
The RNAi machinery of T. brucei consists of a single Argonaute protein (Ago1) and two Dicer-
like enzymes (DCL1 and DCL2) (Ngô et al., 1998; Patrick et al., 2009; Shi et al., 2006). Most 
trypanosome siRNAs are produced from two classes of retrotransposons (ingi and SLACS), 
followed by centromeric CIR147 repeats, long inverted repeats and convergent transcription 
units (Tschudi et al., 2012). These observations suggest that, similarly to other eukaryotes, 
RNAi is protecting the trypanosome genome from the spread of transposable elements and is 
potentially involved in centromeric heterochromatin formation. 
T. brucei encodes a putative DNA methyltransferase which was identified based on sequence 
similarity to a bacterial DNA methyltransferase gene and was found to be expressed in both 
bloodstream and procyclic parasites (Militello et al., 2008). The same study found modest 
amount of 5-methylcytosine (5mC) at both developmental stages of T. brucei. However, an 
unpublished bisulfite sequencing data from the Allshire lab did not identify any genomic loci 
that are highly methylated in the population of BF or PF parasites. This suggested that either 
there is no DNA methylation or low levels of 5mC are present stochastically across the 
trypanosome genome.  
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Bloodstream form trypanosomes have a modified thymidine residue, termed base J, which is 
bulkier than 5-mC (Gommers-Ampt et al., 1993) and is found at transcription termination sites 
and telomeric regions (Schulz et al., 2016). The absence of base J in the procyclic form was 
demonstrated by an anti-J dot-blot test (Van Leeuwen et al., 1997). Base J is found in 
kinetoplastids and a few other closely related organisms (Borst and Sabatini, 2008). It is 
synthesized by J binding protein 1 (JBP1), J biosynthesis protein 2 (JBP2) and a ß-
glucosyltransferase (Figure 1.11). While both JBP1 and JBP2 are thymidine hydroxylases 
catalysing the first step of base J production, JBP1 was found to be involved in J maintenance 
(Cross et al., 2002) and JBP2 – in de novo J synthesis (DiPaolo et al., 2005; Kieft et al., 2007). 
It was previously thought that base J could be involved in gene silencing because of its 
association with silent telomeric VSG genes. This hypothesis was disproven upon the 
observation that JBP1 single and JBP1/JBP2 double knockouts resulted in a marked decrease 
or absence of base J, respectively, but that did not lead to cell lethality or derepression of 
silent VSG genes (Borst and Sabatini, 2008). A second idea, based on analogy with 5mC 
function, was that base J represses homologous recombination between repetitive sequences 
but this hypothesis was also rejected (Cross et al., 2002). Thus, at present, the precise 











              
Figure 1.11 Base J synthesis.  
(A) Synthesis mechanism. The first step of base J synthesis is oxidation of a thymidine residue 
to hydroxymethyldeoxyuridine (HOMedU). In the second step, HOMedU is glucosylated to 
form base J. 
(B) Domain architecture of JBP1 and JBP2. The shared homologous region of JBP1 and JBP2 
is shaded in red. TH – thymidine hydroxylase catalytic domain; JBD – J-binding domain; 
SWI2/SNF2 – family of ATPase/DNA helicases. 











1.3 Trypanosome gene expression 
Most genes in T. brucei are transcribed from polycistronic transcription units (PTUs) which, 
unlike bacterial operons, often contain functionally unrelated genes. mRNAs in a polycistron 
are resolved by trans-splicing of an m7G-capped 39-nt spliced leader (SL) sequence at the 5′ 
end of the mRNA and polyadenylation at the 3′ end (Günzl, 2010). 
1.3.1 RNAPII transcription   
Trypanosome RNAPII transcription start regions (TSRs) are not well characterized with the 
exception of the SL TSR which is defined by a loose consensus motif (Gilinger, 2001). Due to 
the high demand for SL RNA, T. brucei harbours ~200 tandem copies of the SL gene which 
are one of the few trypanosome genes transcribed monocistronically. Within a polycistronic 
RNAPII PTU, genes are arranged in a head-to-tail fashion and are transcribed from the same 
DNA strand. Transcription usually initiates from broad (~10 kb) GT-rich divergent strand-
switch regions (SSRs) and terminates at convergent strand-switch regions (Daniels et al., 
2010; Wedel et al., 2017) (Figure 1.12). TSRs are marked by the presence of H2AZ, H2BV, 
H3K4me3, H4K10ac and TTRs – by H3V, H4V and base J (Schulz et al., 2016; Siegel et al., 
2009; Wright et al., 2010). RNAPII transcription can also terminate at non-SSRs upon 
encounter of RNAPI or RNAPIII transcribed genes (e.g. rRNAs and tRNAs) (Marchetti, 1998; 






Figure 1.12 RNAPII PTU organization. Divergent SSRs are probable transcription start 
regions and convergent SSRs – probable termination regions. The figure shows four PTUs 
with individual genes depicted as orange boxes. Transcription direction within each PTU is 
marked by green arrows. Specific marks of TSRs and TTRs are listed below these regions.  
 
The trypanosome RNAPII has 12 subunits which are homologous to those found in other 
eukaryotes (Das et al., 2008). The basal transcription factors include conserved and divergent 
proteins: TBP(TRF4), TFIIA, TFIIB, TFIIH, Mediator complex, a PAF complex and two proteins 
specific to kinetoplastids (Clayton, 2014; Lecordier et al., 2007; Lee et al., 2010; Ouna et al., 
2012; Ruan et al., 2004; Schimanski et al., 2005; Srivastava et al., 2017). The C-terminal 
domain (CTD) of the largest RNAPII subunit in T. brucei is phosphorylated and is required for 
mRNA production, similarly to other eukaryotes (Das et al., 2017). However, the trypanosome 
RNAPII CTD lacks the classic heptad repeats and the significance of the phosphorylated 
residues for the regulation of mRNA synthesis is unclear. 
1.3.2 RNAPI transcription 
In T. brucei, RNAPI transcribes not only rRNA genes but also VSG and procyclin mRNAs 
(Gunzl et al., 2003). The reason for this could be the high demand for producing surface 
proteins as RNAPI transcription can give ~10 times greater mRNA output than RNAPII 
transcription (Clayton, 2014).  
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Procyclin genes are transcribed from PTUs found in the core of megabase chromosomes 6 
and 10 (Haenni et al., 2006).  In contrast, VSGs are transcribed from expression sites found 
in the subtelomeres of megabase and intermediate chromosomes. The single active VSG in 
the bloodstream form is transcribed from a BES which localises to a special subnuclear 
compartment – the expression site body (ESB) (Navarro and Gull, 2001). ESB is a second, 
non-nucleolar focus of RNAPI in the trypanosome nucleus. BESs are large polycistronic 
transcription units (~50 kb) that include several expression site-associated genes (ESAGs) 
and a single telomere-proximal VSG gene (Figure 1.13). The function of most ESAGs is 
unknown, with the exception of ESAG4 which encodes an adenylate cyclase (Salmon et al., 
2012), ESAG6 and ESAG7 which together encode a transferrin uptake receptor (Steverding, 
1995) and ESAG10 which codes for a folate receptor (Dewar et al., 2016). Between the 
ESAGs and the VSG gene there is a stretch of AT-rich 70 bp repeats.  
 
 
Figure 1.13 BES organisation. A BES is a subtelomeric polycistronic unit consisting of 








VSG switching can occur via two mechanisms. During an in situ (transcriptional) switch, one 
ES is silenced while another ES is activated (Van der Ploeg et al., 1984). More commonly, 
switching occurs by recombination of a new VSG into the active BES (Robinson et al., 1999). 
Recombinational switches are facilitated by homology of regions within the VSG gene or 
proximal to it (such as the 70 bp repeats) as well as the inherent instability of the subtelomeric 
regions which are hot spots for recombination (Horn, 2014). Additionally, fragments of several 
VSG genes can recombine together into the active BES to form a mosaic VSG, further 
expanding the repertoire of trypanosome surface proteins used to evade the host immune 
system.  
The order in which VSGs are expressed during infection is semi-predictable, as demonstrated 
by the preferential expression of certain VSGs at the initial peaks of parasitaemia and 
throughout the later stages of a chronic infection (Morrison et al., 2005). During the course of 
an infection, in situ switches are initially favoured followed by recombinational switches, with 
generation of mosaic VSGs dominating the late stages of trypanosomiasis. Additionally, 
parasites with shorter VSGs were found to dominate early in infection (Liu et al., 2018). This 
could be explained by the lower metabolic costs required to produce shorter VSGs leading to 
faster trypanosome growth rates. 
1.3.3 Post-transcriptional gene regulation 
It is thought that T. brucei regulates its gene expression predominantly post-transcriptionally 
via control of RNA stability and translation. The reason for this is two-fold: firstly, most of the 
trypanosome genes are transcribed from polycistronic units which contain functionally 
unrelated genes whose expression needs to be regulated separately. A notable exception are 
the VSG genes whose expression is regulated transcriptionally. Secondly, RNA binding 
proteins (RBPs) play an important role in trypanosome post-transcriptional gene regulation via 
binding to AU-rich elements (AREs) present in the 3′ UTRs of target RNAs (Clayton, 2002; 
Mayho et al., 2006). For example, it has been shown that RBP6 is sufficient for the procyclic 
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to metacyclic differentiation (Kolev et al., 2012), and RBP10 – for promoting the procyclic to 
bloodstream transition (Mugo and Clayton, 2017). However, it is unclear how the expression 
of these RBPs is itself regulated. Additionally, it has recently been demonstrated that depletion 
of retrotransposon hot spot (RHS) genes reduces nascent RNAPII transcription and leads to 
accumulation of mRNAs in the nucleus, suggesting that RHS genes are involved in the 
regulation of RNAPII transcription elongation and mRNA export (Florini et al., 2018). These 
findings indicate that there is a transcriptional component to trypanosome gene regulation. 
1.4 Project aims 
The aim of this project was to assess what role histone modification readers, writers and 
erasers play in trypanosome chromatin organisation and transcription regulation. To address 
this question, the following approaches were used: 
(i) Identification, tagging and localisation of putative readers, writers and erasers of 
histone modifications in T. brucei 
(ii) Chromatin immunoprecipitation and sequencing (ChIP-seq) of the nuclear 
candidate proteins to identify associated genomic regions 
(iii) Co-immunoprecipitations followed by mass spectrometry to characterise candidate 









Materials and methods 
2.1 Trypanosome methods 
2.1.1 Trypanosome cell culture 
Lister 427 bloodstream and procyclic cell lines were used throughout this project. The potential 
history of these cell lines was recorded by George Cross: 
http://tryps.rockefeller.edu/trypsru2_pedigrees.html.  
 
Bloodstream form monomorphic cell lines were grown at 37oC and 5% CO2 in HMI-9 medium 
(Appendix A) supplemented with 10% Fetal Calf Serum (Gibco), 1% Penicillin-Streptomycin 
(Gibco) and selective drug(s) (when appropriate) (Hirumi and Hirumi, 1989). Cells cultures 
were maintained below 3 x 106 cells/ml.  
Procyclic form cell lines were grown at 27oC in SDM-79 medium (Appendix A) supplemented 
with 10% Fetal Calf Serum (Gibco), 1% Penicillin-Streptomycin (Gibco), 0.1% hemin and 
selective drugs (when appropriate) (Brun, 1979). Cell cultures were maintained between 5 x 
105 and 3 x 107 cells/ml. 
Glycerol stocks were made by mixing 500 µl trypanosome cell culture with 500 µl of the 
appropriate medium containing 28% glycerol (final glycerol concentration was 14%). Cryovials 
were incubated overnight at -80oC in a polystyrene container (to prevent ice crystal formation) 
before being moved to a box in a -80oC freezer or in liquid nitrogen for long-term storage.  
Glycerol stocks of bloodstream cells were thawed by adding the contents of the cryovial to 5 
ml HMI-9 medium without selective drugs and centrifuging at 1000 g for 10 min to remove 
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glycerol. The cell pellet was resuspended in 5 ml HMI-9 medium and incubated overnight at 
37oC and 5% CO2 before adding selective drug(s) (if appropriate). 
Glycerol stocks of procyclic cells were thawed by adding the contents of the cryovial to 5 ml 
SDM-79 medium without removing glycerol and incubating overnight at 27oC before adding 
selective drug(s) (if appropriate). 
Table 1 Cell lines with drug resistances used in this study 
Cell lines Selective drug Concentration 
 















1 x 106 parasites were harvested by centrifugation at 4000 g for 5 min. The cells were washed 
once with 500 µl cold 1X PBS and centrifuged again at 4000 g for 5 min.  The cells were fixed 
by resuspending the pellets in 125 µl cold 1X PBS + 125 µl 8% paraformaldehyde and 
incubating on ice for 10 min. The fixed samples were centrifuged at 4000 g for 5 min and the 
cells were resuspended in 130 µl 0.1 M glycine (diluted in 1X PBS). The cells were incubated 
overnight at 4oC, centrifuged at 4000 g for 5 min and resuspended in 200 µl 1X PBS. Wells 
were drawn on polylysine slides using a hydrophobic pen. 10 µl cells were added to each well 
and the slides were incubated for 1 h at room temperature in a humid chamber to let the 
parasites stick to the wells. The excess PBS was removed using a vacuum pump and 0.1% 
Triton X-100 (diluted in 1X PBS) was added to the wells for 2 min in order to permeabilise the 
cells. The slides were washed with 1X PBS for 5 min on a lab rocker. The samples were 
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blocked in 2% BSA (diluted in 1X PBS) for 45 min at 37oC inside a humid chamber. Excess 
blocking solution was removed with a vacuum pump and the cells were incubated with a 1:500 
dilution (in 2% BSA) of the primary antibody, rabbit anti-GFP (Thermo Fisher Scientific), for 
45 min at 37oC inside a humid chamber. The slides were then washed 3 x 5 min with 1X PBS 
on a lab rocker. The cells were incubated with 1:1000 dilution (in 2% BSA) of the secondary 
antibody, Alexa Fluor 568 goat anti-rabbit (Thermo Fisher Scientific) for 45 min at 37oC inside 
a humid chamber. From here on, the slides were kept in the dark as much as possible to 
prevent photobleaching of the secondary antibody signal. The slides were washed 2 x 5 min 
with 1X PBS on a lab rocker, incubated with 1µg/ml DAPI for 2 min and washed again 2 x 5 
min with 1X PBS.  Coverslips were mounted onto the slides by adding a few drops of mowiol 
+ DABCO (Appendix A) and sealing with nail polish. The slides were left to dry overnight at 
room temperature in the dark before visualisation under the microscope (Zeiss Axio Imager).  
2.1.3 Trypanosome transfections  
Approximately 5 x 107 bloodstream or procyclic cells were harvested per transfection by 
centrifugation at 1000 g for 10 min. The cells were washed once with 5 ml media (HMI-9 or 
SDM-79) and pelleted again by centrifugation at 1000 g for 10 min before resuspending them 
in 100 µl ice-cold transfection buffer, Amaxa or homemade (Appendix A), and transferring 
them to an electroporation cuvette (Ingenio). 10-20 µl containing 100 ng - 5 µg DNA were then 
added to the cuvette. The cells were mixed with the DNA by flicking and electroporated in 
Amaxa Nucleofector II (Lonza) using the X-001 programme for bloodstream cells and the Z-
001 programme for procyclic cells. A “no DNA” mock transfection was performed in parallel 
as a control.  
Electroporated bloodstream cells were added to 30 ml HMI-9 medium and two 10-fold serial 
dilutions were performed. 1 ml of transfected cells were plated per well on 24-well plates (1 
plate per dilution) and incubated at 37oC and 5% CO2 for 6 h before adding 1 ml media 
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containing 2X concentration of the selective drug per well. The mock-transfected cells were 
dead by day 5 post-transfection and then genuine transfectants were moved to flasks. 
Electroporated procyclic cells were added to 6 ml SDM-79 medium and incubated overnight 
at 27oC before being mixed with 6 ml media containing 2X concentration of the selective drug. 
Two 24-well plates per transfection were set up as follows: 
Plate 1 
row A – 2 ml cell culture (+1X final drug concentration) 
row B – 1.5 ml SDM-79 + 1X drug 
row C – 1.5 ml SDM-79 + 1X drug 
row D – 1.0 ml SDM-79 + 1X drug 
 
Plate 2 
row A – 1.0 ml SDM-79 + 1X drug 
row B – 0.5 ml SDM-79 + 1X drug 
Serial dilutions were performed by transferring 500 µl from well A1 (row A, column 1) on plate 
1 to well B1 (row B, column 1) on plate 1. The dilutions were continued in the same fashion 
until row B on plate 2. The mock-transfected cells were dead by day 7-9 post-transfection and 







2.2 Standard DNA methods 
2.2.1 Ethanol precipitation 
Various DNA samples required cleaning of impurities and/or concentration. This was done via 
ethanol precipitation. 0.1 V of 3 M sodium acetate pH 5.2 and 2.5 V of ice-cold 100% ethanol 
were added to the DNA. The samples were precipitated at -80oC for 1 h or at -20oC overnight. 
The samples were then centrifuged at 16 000 g for 15 min at 4oC. The supernatant was 
discarded, and the DNA was washed once with ice-cold 70% ethanol. The samples were 
centrifuged again at 16 000 g for 15 min at 4oC, the supernatant was discarded, and the DNA 
was air-dried for 10 min at room temperature. Finally, the DNA was resuspended in the desired 
volume of distilled water and the resulting concentration was measured by NanoDrop (Thermo 
Fisher Scientific). 
2.2.2 Genomic DNA extraction   
Approximately 4 x 107 cells from bloodstream or 1 x 108 cells from procyclic cultures were 
harvested by centrifugation at 1000 g for 10 min. The cells were then washed once with 500 
µl 1X PBS and pelleted again by centrifugation at 1000 g for 10 min. Genomic DNA was 
extracted using DNeasy Blood & Tissue kit (Qiagen) following the manufacturer’s instructions. 
The DNA samples were ethanol precipitated and the amount of extracted DNA was quantified 
using NanoDrop (Thermo Fisher Scientific). 
2.2.3 Polymerase chain reaction (PCR) 
PCR amplifications of DNA were carried out in 0.2 ml PCR tubes (STARLAB) in an MJ 
Research PTC-225 Gradient Thermal Cycler (Marshall Scientific). 10-200 ng DNA was used 
as template. All primers (Appendix B) were purchased from Integrated DNA Technologies. 
PCR amplifications aiming to confirm the presence of a DNA fragment in a sample were 
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carried out with Taq DNA Polymerase (Roche) whereas PCRs for cloning purposes were done 
using high-fidelity DNA polymerases - Phusion High-Fidelity DNA Polymerase (New England 
Biolabs) or Platinum Pfx DNA Polymerase (Thermo Fisher Scientific).  
2.2.4 DNA agarose gel electrophoresis 
DNA fragments in a sample were separated by size via agarose gel electrophoresis. Usually, 
1% agarose was used except for resolving very large (> 2kb) or very small (< 500 bp) 
fragments for which 0.8% and 2% agarose solutions were used, respectively. The agarose 
powder was dissolved by boiling in 1X TBE (Appendix A) buffer except for DNA gel extractions 
when 1X TAE (Appendix A) buffer was used. The solution was cooled down to approximately 
60oC before adding 0.3 µg/ml ethidium bromide (Sigma-Aldrich). The gel was poured into a 
cast containing a gel comb and left to solidify, then transferred to a gel tank filled with 1X TBE 
or 1X TAE buffer, as appropriate.  DNA samples were resuspended in loading dye (NEB) and 
loaded in the gel wells alongside a DNA ladder that allowed estimation of the fragment sizes. 
The gels were run at 100-120 V for time sufficient to resolve the desired fragments. 
2.2.5 DNA gel extraction 
When a PCR reaction resulted in amplification of multiple fragments in addition to the desired 
one, the correct amplicon was purified from the agarose gel using NucleoSpin Gel and PCR 
Clean-up kit (Macherey-Nagel) following the manufacturer’s instructions. The eluted DNA was 
ethanol precipitated and the resulting sample concentration was measured by NanoDrop 





2.2.6 Plasmid restriction digests 
Plasmids were digested with restriction enzymes from NEB following the manufacturer’s 
instructions. Usually, a single or a double digest was performed in CutSmart Buffer (NEB) at 
37oC for 1 h followed by enzyme inactivation at 80oC for 20 min.  
2.2.7 Bacterial transformations 
DH5α (NEB) or XL10-Gold (Agilent technologies) competent E. coli cells were stored at -80oC 
and thawed on ice immediately before transformation. Approximately 1-5 µl of a plasmid 
ligation reaction or 0.5-1 µl of a plasmid preparation were added to 30-50 µl competent cells 
and the mixture was incubated on ice for 30 min. The cells were then heat-shocked at 42oC 
for 40 s and put on ice for 5 min. 950 µl of LB medium (Appendix A) was added to the cells 
which were then incubated at 37oC for 1 h with shaking to allow them to recover. Finally, the 
cells were plated onto LB selective plates containing 100μg/ml ampicillin (all plasmids used in 
this study had an ampicillin resistance gene) and incubated at 37oC overnight. The following 
morning the plates were taken out of the incubator and the success of the transformations 
was assessed by the presence of colonies on the plates.  
2.2.8 Plasmid minipreps 
Single colonies from bacterial transformation plates were grown in 5 ml LB at 37oC overnight 
with shaking. The plasmid isolation was done using either a QIAprep Spin Miniprep Kit 
(QIAGEN) or a Monarch Plasmid Miniprep Kit (NEB) following the manufacturers’ instructions. 
The amount of DNA in the plasmid preparations was quantified by NanoDrop 




2.3 Standard protein methods 
2.3.1 Protein extraction 
4 x 107 bloodstream or procyclic cells were harvested by centrifugation at 1000 g for 10 min. 
The cells were washed once with 500 µl 1X PBS and resuspended in 75 µl 1X PBS + 25 µl 
4X NuPAGE LDS Sample Buffer (Thermo Fisher Scientific). The samples were then boiled at 
95oC for 5 min.  
2.3.2 Western blot analysis 
Whole cell protein extracts were separated by polyacrylamide gel electrophoresis (PAGE). 
Protein from 4 x 106 cells was loaded per lane in NuPAGE Bis-Tris Mini Gels (Thermo Fisher 
Scientific). Samples were run for 30 – 60 min in a Mini Gel Tank (Thermo Fisher Scientific) in 
1X NuPAGE MES Running Buffer or 1X NuPAGE MOPS Running Buffer (Thermo Fisher 
Scientific) depending on the protein sizes that had to be resolved. For separation of smaller 
proteins, shorter run times and MES buffer was used. Conversely, larger proteins were 
separated with longer run times and MOPS buffer. Following PAGE, proteins were transferred 
onto nitrocellulose membranes in a Mini Blot Module (Thermo Fisher Scientific) at 20 V for 1 
h. The success of the transfer was assessed by staining the membranes with Ponceau S 
(Sigma-Aldrich). Membranes were then blocked in 5% milk powder in PBS-T (PBS + 0.05% 
tween) at room temperature for 30 min. After blocking, membranes were incubated with a 
1:1000 dilution (in 5% milk in PBS-T) of the primary antibody, mouse anti-GFP (Roche), at 
4oC overnight on a lab rocker. The membranes were washed 3 x 10 min with PBS-T on a lab 
shaker and incubated with a 1:2500 dilution (in 5% milk in PBS-T) of the secondary antibody, 
HRP-conjugated anti-mouse, at room temperature for 1 h on a lab shaker. The membranes 
were washed again 3 x 10 min with PBS-T. Finally, proteins were detected with Amersham 
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ECL Prime Western Blotting Detection Reagent (GE Healthcare) following manufacturer’s 
instructions and visualised using Amersham Hyperfilm ECL (GE Healthcare). 
2.4 Chromatin immunoprecipitation and sequencing (ChIP-seq) 
2.4.1 ChIP 
4 x 108 cells were harvested per ChIP sample by centrifugation at 1500 g for 10 min. The cell 
pellets were resuspended in 40 ml HMI-9 or SDM-79 media, as appropriate, and then 4 ml 
formaldehyde solution (Appendix A) was added to each sample. The cells were fixed with 
0.8% final formaldehyde concentration for 20 min at room temperature. The fixation was 
stopped by the addition of 2.5 ml 2 M glycine, followed by centrifugation at 1500 g for 20 min 
at 4oC. The resulting cell pellets were washed once with 10 ml cold 1X PBS and centrifuged 
at 3500 g for 20 min at 4oC. The next steps involving Lysis buffers 1 and 2 were performed 
without resuspending the pellets by pipetting to avoid cells sticking to the plastic tips. Vigorous 
shaking of the samples was used instead. The pellets were first resuspended in 2.5 ml Lysis 
buffer 1 (Appendix A), supplemented just before use with EDTA-free protease inhibitor tablets 
(Roche). The samples were incubated at 4oC for 10 min on a lab rocker and then centrifuged 
at 3500 g for 20 min at 4oC. The resulting pellets were resuspended in 2.5 ml Lysis buffer 2 
(Appendix A), supplemented just before use with EDTA-free protease inhibitor tablets (Roche) 
and incubated at room temperature for 10 min on a lab rocker. The samples were then 
centrifuged at 3500 g for 20 min at 4oC. The pellets were resuspended in 300 µl Lysis buffer 
3 (Appendix A), supplemented just before use with SDS (0.2% final concentration) and EDTA-
free protease inhibitor tablets (Roche), and transferred to microfuge tubes. The chromatin was 
fragmented by sonication at a high setting in a Bioruptor (Diagenode) sonicator at 5°C for 30 
cycles (30 s ON / 30 s OFF per cycle). After sonication, 900 µl Lysis buffer 3, supplemented 
with protease inhibitors but not SDS, was added to each sample. The samples were then 
centrifuged at 16000 g for 10 min at 4°C and the resulting supernatants were transferred to 
43 
 
new microfuge tubes. At this stage, 10 µl ‘’input’’ was taken from each sample and frozen 
overnight at -80°C. The rest of the sample, the ‘’IP’’, was incubated rotating overnight at 4°C 
with 10 µg rabbit anti-GFP antibody (Thermo Fisher Scientific) and 50 µl Protein G Dynabeads 
(washed beforehand 2x with Lysis buffer 3). Thus, the antibody/bead crosslinking and the IP 
steps were combined together.  
The following day, the beads were collected using a magnet and the supernatant was 
discarded. The beads were first washed with 900 µl Lysis buffer 3 on a magnet. The beads 
were then washed with 900 µl Wash buffer 1 (Appendix A) rotating for 10 min at 4°C, followed 
by a wash with 900 µl Wash buffer 2 (Appendix A) rotating for 10 min at 4°C. The last wash 
was with 900 µl TE buffer (Appendix A) on a magnet and during that wash the beads were 
transferred to a new microfuge tube. This was done because DNA sticks to the plastic of 
microfuge tubes and consequently the washes cannot efficiently remove unspecific DNA from 
the sample. 200 µl Elution buffer (Appendix A) was added to the washed beads (IPs) as well 
as the inputs and the samples were then incubated overnight at 65°C with shaking at 1000 
rpm, combining together the elution and reverse crosslinking steps. 
The next day, the beads were separated from the eluate on a magnet and discarded. 10 µl 
DNAse-free RNAse (Roche) was added per eluate which was then incubated at 37°C for 2 h 
shaking at 1000 rpm. Then, 8 µl Proteinase K (10 mg/ml) was added per sample which was 
subsequently incubated at 55°C for 2 h shaking at 1000 rpm. Finally, the DNA was purified 
using a QIAquick PCR Purification Kit (Qiagen) and quantified by a Qubit fluorometer using 
Qubit dsDNA HS Assay Kit (Invitrogen).  
2.4.2 Library preparation 
Library preparation of ChIP DNA was done in Eppendorf RNA/DNA LoBind Microfuge Tubes 
(Sigma-Aldrich) except the PCR step. 0.5-20 ng DNA was blunt ended at room temperature 
for 45 min using a Quick Blunting Kit from NEB. DNA was then purified using AMPure beads 
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(Beckman Coulter) with a bead:DNA sample ratio of 1.6:1. DNA was A-tailed using Klenow 
Fragment (3'→5' exo-) from NEB for 30 min at 37°C. Samples were incubated at 75°C for 5 
min to heat-inactivate the enzyme and then placed on ice for 5 min. NEXTflex (Bioo Scientific) 
adapters containing barcodes were ligated immediately after A-tailing for 25 min at room 
temperature using a Quick Ligation Kit from NEB. Samples were purified 2x using a 1:1 ratio 
with AMPure beads. DNA was PCR amplified (16-18 cycles) and subsequently subjected to 
size selection with AMPure beads in several rounds. First, a “right-hand” purification was done 
with a bead:DNA sample ratio of 0.65:1 and the supernatant resulting after binding was taken 
for a 0.7:1 bead:sample AMPure purification. Finally, two 1:1 AMPure purifications were 
performed. The resulting library was quantified by Qubit fluorometer using Qubit dsDNA HS 
Assay Kit (Invitrogen). Fragment size distribution was assessed by 2100 Bioanalyzer 
Instrument (Agilent Technologies) using a Bioanalyzer High Sensitivity DNA Analysis kit 
(Agilent). Ideally, the libraries had a peak at 300 bp (~ 150 bp fragment DNA + ~ 150 bp 
adapter sequence). Libraries were sequenced on Illumina MiniSeq (Allshire lab), HiSeq 4000 
(Edinburgh Genomics) or NextSeq (Western General Hospital, Edinburgh). In all cases, 75 bp 
paired-end sequencing was performed. 
2.4.3 ChIP-seq data analysis 
FASTQ files (Cock et al., 2010) were processed to bigWig format (Kent et al., 2010) for 
visualisation in a genome browser as follows. The sequencing reads were first subjected to 
quality control using FastQC (Andrews, 2018). Duplicates were then removed via 
pyFastqDuplicateRemover (Webb et al., 2018) and the reads were subsequently aligned to 
the Tb427v9.2 genome (Müller et al., 2018) using Bowtie2 (Langmead and Salzberg, 2012). 
The resulting SAM files (Li et al., 2009) were converted to BAM format (Li et al., 2009), then 
sorted and indexed. IPs were normalised to the respective inputs and to the library size via 
bamCompare (Ramírez et al., 2016). The output of bamCompare were bigWig files (Kent et 
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al., 2010) which were visualised using Integrative Genomics Viewer (IGV) (Robinson et al., 
2011). 
Metagene plots were generated as follows. Chromo1 peaks were called by MACS2 (Feng et 
al., 2012). 20 kb regions around Chromo1 peak summits were divided into 50 bp windows. 
For each protein, the reads in each window were counted using pyReadCounters (Webb et 
al., 2018). The reads around all Chromo1 peaks were added up, normalised to library size and 
input and represented as a density plot, centred around the Chromo1 peak summits. The 
average metagene plots were generated analogously, except that the reads around Chromo1 
peaks were averaged before plotting. 
Heatmaps were generated as follows. Chromo1 peaks were called by MACS2 (Feng et al., 
2012). 20 kb regions around Chromo1 peak summits were divided into 50 bp windows. For 
each protein, the reads in each window were counted using pyReadCounters (Webb et al., 
2018). The reads around individual Chromo1 peaks were normalised to library size and input 
and represented as a density plot, centred around the Chromo1 peak summits. Each heatmap 
was generated as an average of all replicates for the particular protein. 
2.5 Protein immunoprecipitation (IP) and mass spectrometry analysis 
2.5.1 Crosslinking of antibody to magnetic beads 
All crosslinking steps were performed at room temperature. 1 ml Protein G Dynabeads 
(Thermo Fisher Scientific) were washed 2 x 1 ml Lysis buffer MS (Appendix A). 1 vial of mouse 
anti-GFP antibody (Roche) was resuspended in 1ml Lysis buffer MS and added to the beads. 
The beads were rotated for 30 min. The beads were washes 2 x 1 ml Lysis buffer MS on 
magnet and added to 10 ml Borate buffer (Appendix A) supplemented with 50 mg DMP 
(Thermo Fisher Scientific). Only DMP opened within one month of the experiment was used. 
The beads were rotated for 30 min, washed once with 10 ml Lysis buffer MS and resuspended 
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in 2 ml Lysis buffer MS. The antibody-crosslinked beads could then be stored at 4°C for 
several months.  
2.5.2 Protein IP 
4 x 108 cells were harvested per IP by centrifugation at 1500 g for 10 min. The cells were 
washed once with cold PBS and centrifuged at 1500 g for 10 min. The resulting pellets were 
resuspended in 200 µl Lysis buffer MS, supplemented just before use with EDTA-free 
protease inhibitor tablets (Roche), and incubated on ice for 15 min. The samples were 
sonicated at a high setting in a Bioruptor (Diagenode) sonicator at 5°C for 3 cycles (12 s ON / 
12 s OFF per cycle). The chromatin and soluble fractions were separated by centrifugation at 
16000 g for 5 min at 4°C. The soluble fraction was taken for the IP. 120 µl of antibody-
crosslinked beads were added per sample and the IPs were rotated for 1 h at 4°C. The 
samples were washed 3 x 1 ml Lysis buffer MS on magnet and the protein was eluted with 40 
µl RapiGest surfactant (Waters) at 55°C for 15 min. Only RapiGest resuspended within one 
week of the experiment in 50 mM Tris-HCl pH 8.0 was used. 
2.5.3 FASP digestion 
DTT was added to each sample to a final concentration of 25 mM. The samples were 
incubated at 95°C for 5 min and then let stay at room temperature until cooled. The samples 
were mixed with 100 µl 8 M Urea in 0.1 M Tris-HCl pH 8.0 and transferred to Vivakon spin 
(filter) column 30K cartridge. The columns were centrifuged at 12000 g for 10-15 min. 100 µl 
0.05 M IAA (in 8 M Urea in 0.1 M Tris-HCl pH 8.0) was added to each column. The samples 
were shaken at 600 rpm for 1 min at room temperature and then incubated in the dark for 20 
min at room temperature. The columns were centrifuged at 12000 g for 10-15 min and then 
100 µl 8 M Urea in 0.1 M Tris-HCl pH 8.0 was added to each column. The columns were 
centrifuged at 12000 g for 10-15 min and then washed 2 x 100 µl ABC buffer (Appendix A). 
Only fresh ABC buffer made within one week of the experiment was used. The ABC buffer 
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was prepared with MS grade water and the pH was assessed with pH indicator paper. Each 
sample was digested with 0.5 µg MS Grade Pierce Trypsin Protease (Thermo Fisher 
Scientific) in 100 µl ABC buffer overnight at 37°C. 
2.5.4 Stage tip preparation 
After overnight trypsin digestion, the columns were centrifuged at 12000 g for 15 min, then 
washed with 100 µl ABC buffer and centrifuged again at 12000 g for 15 min. The samples 
were acidified to pH 2-3 (assessed with pH indicator paper) with ~ 10 µl 10% TFA.  
Stage tips (Rappsilber et al., 2007) were prepared as follows. Three C-18 paper discs were 
cut out and placed in a tip. The stage tips were conditioned by sequential passing though 
centrifugation at 1000 g of 50 µl methanol, 50 µl 80% ACN in 0.1% TFA and 50 µl 0.1% TFA, 
in this order. The protein samples were then loaded onto the tips at 800 g for 30 min. The 
stage tips were washed with 75 µl 0.1% TFA and frozen at -20°C. Dr Tania Auchynnikava 















Tagging and localisation of putative readers, writers and erasers of 
histone post-translational modifications in T. brucei 
3.1 Introduction 
The interplay between reading, writing and erasing of specific histone post-translational 
modifications facilitates, among other things, the organisation of chromatin into active and 
silent domains which may be constitutive or change depending on the cell type, developmental 
stage and environmental stimuli sensed by the organism. These chromatin regulation activities 
have been attributed to particular protein domains. For example, a histone methyl mark could 
be deposited by a SET-domain protein, read by a Chromo-domain protein and removed by a 
Jmj-domain protein. 
Proteins containing domains associated with reading, writing and erasing of histone PTMs can 
be found in the trypanosome genome but their functions are largely unknown. Together with 
Dr Roberta Carloni, we initiated characterisation of these proteins by endogenous ORF 
tagging followed by examination of their cellular localisation. The goal was to narrow down the 
list of candidate proteins to those present in the nucleus which may be involved in 
trypanosome chromatin organisation and gene expression regulation. We decided to focus on 
proteins likely to be involved in depositing, binding or removing acetyl and methyl marks as 






3.2 Selection and tagging of the candidate proteins 
We identified 71 putative readers, writers and erasers of histone acetyl and methyl marks 
based on their predicted protein domains (Table 3.1). Of these, 68 proteins were successfully 
tagged with YFP and localised microscopically in bloodstream form parasites: 16 were found 
to be nuclear, 29 were exclusively cytoplasmic, and 23 localised both in the nucleus and in 
the cytoplasm.  
Ago1, the only Argonaute protein in T. brucei, was also tagged in addition to the putative 
chromatin modifiers because of the link between RNAi and heterochromatin formation in other 
eukaryotes (Allshire and Madhani, 2018). 
When available, existing protein names from the TriTryp database (www.tritrypdb.org) were 
used. Proteins annotated as “hypothetical” in TriTrypDB were given names in this project. To 
avoid ambiguity, the unique gene codes for the candidate proteins discussed in this thesis can 
be found in Tables 3.2 and 6.1. 
N-terminal tagging was chosen to avoid interference with the 3′ UTRs which contain 
sequences known to control mRNA stability (Clayton, 2019). The pPOTv4 plasmid (Dean et 
al., 2015) used for tagging contained, in this order, actin (act) 5′ UTR, blasticidin S deaminase 
(bsr), aldolase (ald) 3′ UTR, actin (act) 5′ UTR, glycine-serine linker (GS10), enhanced YFP 
tag (eYFP), glycine-serine linker (GS10) and PFR2 3′ UTR (Figure 3.1A). The GS10 linkers 
on both sides of the eYFP tag could assist the folding of fusion proteins. The tagging constructs 
were made by fusion PCR of three fragments: a ~500 bp fragment homologous to end of the 
5′ UTR of each gene, a region of the pPOTv4 plasmid containing the blasticidin resistance 
cassette (bsr) and the eYFP tag, and a ~500 bp fragment homologous to the beginning of the 
coding sequence of each gene (Figure 3.1A). The long regions of homology to the 5′ UTR and 
the CDS of each gene were required for efficient homologous recombination and construct 
integration. Tagging constructs (~2.7 kb) were transfected into bloodstream slender 
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(monomorphic) parasites of the Lister 427 strain. The semi-clonal populations (designated as 
“clones” in this thesis for simplicity) obtained after transfection and blasticidin selection were 
tested for correct integration of the tagging construct in the genome by PCR and expression 
of the tagged protein by western blot analysis (Appendix C). Typically, four clones per 
construct were picked after the mock-transfected cells had died. Tagging of a particular protein 
was deemed successful when the construct integration was correct and/or the tagged protein 
was detected by western blot analysis. More emphasis was given to the westerns, although it 
was taken into account that some proteins may not be expressed in all developmental forms 
of the parasite. 
 






Figure 3.1 Tagging strategy.  




Figure 3.1 continued 
(A) Preparation of the tagging constructs by fusion PCR. A fragment containing the bsr gene 
and the eYFP tag was PCR amplified from the pPOTv4 plasmid (the positions of the forward 
and reverse primers are shown as arrows). A ~500 bp fragment was PCR amplified from the 
end of the 5′ UTR of each gene, with a 3′ overhang (shown as a white box) being added by 
the reverse primer. A ~500 bp fragment was PCR amplified from the beginning of the CDS of 
each gene, with a 5′ overhang (shown as a white box) being added by the forward primer. The 
overhangs were complementary to the fragment from the pPOTv4 plasmid and were utilised 
to combine the three fragments together by fusion PCR.   
(B) Tagging construct integration via homologous recombination using homologies within the 
5′ UTR and CDS regions. 
(C) PCR validation for correct integration of the tagging constructs after transfection and 
blasticidin selection. Two primer pairs were used (their positions are shown as arrows): the 
left primer pair tested for correct integration at the 5′ UTR junction and the right primer pair – 
for correct integration at the CDS junction of the candidate protein genes. 
 
 
The tagging strategy is illustrated below for SET27 (Tb927.9.13470). Multiple PCR reactions 
were run in order to amplify sufficient amounts of the pPOTv4, 5′ UTR and CDS fragments 
(Figure 3.2A). The three types of fragments were joined together via several fusion PCR 
reactions (Figure 3.2B). The fusion PCR always generated many unspecific bands. Thus, the 
fusion construct was always gel extracted prior to transfection. Genomic DNA and protein 
were extracted from the four SET27 clones chosen after blasticidin selection to test for correct 





Figure 3.2 SET27 tagging. 
(A) PCR amplification of the SET27 CDS (464 bp) and 5′ UTR (505 bp) fragments and the 
pPOTv4 fragment (1694 bp). 
(B) Production of the SET27 tagging construct (2663 bp) via fusion PCR. 
(C) PCR validation of correct tagging construct integration. Genomic DNA from wt untagged 
cells was used as a negative control. Genomic DNA from the four SET27 clones selected 
showed correct integration of the tagging construct at the CDS (1237 bp) and 5′ UTR (1055 
bp) junctions. 




3.3 Localisation of the candidate proteins 
The YFP tags were used for immunolocalisation of the candidate proteins (Figure 3.3). 
Proteins with known localisation, such as the kinetochore protein KKT2 (Akiyoshi and Gull, 
2014; Llauró et al., 2018), were used as controls. As expected, KKT2 formed discrete puncta 
on opposite poles of the two daughter nuclei during cell division (Figure 3.3). From this section 
onwards, unless otherwise indicated, I present data only for the proteins I tagged and 
subsequently worked on during this project. 
Table 3.2 summarises the candidate protein localisation in the bloodstream form identified in 
this study and compares it to the localisation in the procyclic form as determined in the TrypTag 
project (www.tryptag.org), the aim of which is to tag and localise all T. brucei proteins except 
VSGs (Dean et al., 2017). In TrypTag, proteins were tagged with mNeonGreen (Shaner et al., 
2013) which is approximately the same size as YFP but is brighter and protein localisation can 
be visualised microscopically without antibody staining. As of 5 January 2020, data for 20 out 
of my 34 candidates (59%) were available on TrypTag, and most of these were in agreement 
with my observations. However, a different localisation in the PF was observed for Tudor1, 
HDAC2, Sir2rp3 and LCM1. For two of these proteins, the images and their descriptions on 
TrypTag did not match: Tudor1 was classified as a nuclear and cytoplasmic protein but the 
images shown on the website support an exclusively cytoplasmic localisation; Sir2rp3 was 
described as a cytoplasmic protein but the available images show that it is also present in the 
nucleus. Most candidates were tagged N-terminally in the TrypTag project, with some genes 
(PWWP1, Znf-CW1, SET5, SET21, SET24, SET26 SET30, HDAC2, HDAC3, Sir2rp3, Jmj1) 
also being tagged on the C terminus. In many of the latter cases, changing the position of the 
tag also resulted in an altered cellular localisation, highlighting the fact that tagging can lead 





Figure 3.3 Localisation of the candidate proteins. Candidate proteins were 
immunolocalised in bloodstream form trypanosomes using an anti-GFP primary and a red 
fluorescently labelled secondary antibody. Nuclear and kinetoplast DNA were stained with 




























This Chapter presented data on the tagging and cellular localisation of 8 putative readers, 14 
putative writers and 11 putative erasers of trypanosome histone PTMs as well as data on Ago1 
and control proteins. The candidates chosen were largely uncharacterised with a few 
exceptions. HDAC1 and HDAC3 are essential histone deacetylases, with HDAC1 opposing 
Sir2rp1-dependent telomeric silencing in BF only, whereas HDAC3 is required for VSG ES 
silencing in both BF and PF cells (Alsford et al., 2007; Wang et al., 2010).  
This initial screen for protein localisation showed that 7 of the candidates are nuclear, 17 –
cytoplasmic, and 9 – both nuclear and cytoplasmic. One surprising finding from this survey 
was that the majority of SET-domain proteins are cytoplasmic, and none are exclusively 
nuclear, suggesting that they might methylate non-histone substrates in the cytoplasm.  
One issue with the immunolocalisation methodology used was cytoplasmic background from 
the secondary antibody. Thus, although proteins could be confidently classified as nuclear, 
cytoplasmic localisation was less certain. Since nuclear proteins were of particular interest, 
this drawback was deemed acceptable. 
Comparison with the available TrypTag data showed that in most cases the protein localisation 
is identical in bloodstream and procyclic cells. The two clear differences observed (for HDAC2 
and LCM) could be due to differential localisation of the candidates throughout the 
trypanosome life cycle. No cell cycle differences in localisation were observed during the 
screen in BF parasites.  
Overall, in this Chapter, I laid the groundwork for the remainder of this project by tagging and 
localising proteins which are potentially involved in trypanosome chromatin organisation and 
transcription regulation. In subsequent experiments, the YFP tags were used to perform ChIP-
seq analysis to determine protein distribution across the T. brucei genome, and affinity 




Many of the nuclear putative chromatin regulators are concentrated 
at RNAPII transcription start regions 
4.1 Introduction 
T. brucei is thought to regulate its gene expression predominantly post-transcriptionally. 
However, electron micrographs have shown the presence of darkly stained regions in the 
nuclei of bloodstream and procyclic parasites (Daniels et al., 2010; Rout and Field, 2001) 
which may correspond to transcriptionally inactive heterochromatic regions. The extensive 
reservoir of transcriptionally silent VSGs as well as repetitive elements, such as the ingi and 
SLACS retrotransposons and the centromeric CIR147 repeats, are expected to be found in 
these regions. 
T. brucei’s histones are highly divergent from their counterparts in other eukaryotes. A few 
histone PTMs and histone variants have been implicated in the regulation of trypanosome 
transcription: H3K4me3 and H4K10ac as well as H2AZ and H2BV are found at RNAPII TSRs 
whereas H3V and H4V mark RNAPII termination regions (Siegel et al., 2009; Wright et al., 
2010).  In general, however, detailed characterisation of trypanosome histone PTMs and their 
regulators is lacking. 
To determine if any of the putative readers, writers and erasers of histone marks identified in 
Chapter 3 are involved in chromatin organisation, the YFP-tagged candidate proteins with 
nuclear localisation were analysed by ChIP-seq to assess their association with and 
distribution across the genome. It was hypothesised that some proteins may be enriched at 
repetitive elements or silent VSG arrays which would indicate that they play a role in 
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trypanosome chromatin silencing. Conversely, candidates found at TSRs or over polycistronic 
transcription units could be exerting positive or negative regulation on transcription. 
4.2 Candidate protein enrichment at RNAPII TSRs 
ChIP-seq was performed on the nuclear and nuclear and cytoplasmic candidate proteins. The 
untagged Lister 427 cell line was used as a negative control and a YFP-tagged kinetochore 
protein (KKT2) was included as a positive control. ChIP-seq was also performed on Ago1 
which microscopically appeared cytoplasmic but was suspected to interact with chromatin, 
analogously to its association with siRNA producing loci in other eukaryotes (Allshire and 
Madhani, 2018). Two ChIP-seq replicates were performed for each cell line except Chromo1 
for which three replicates were performed. Thus, a total of 94 samples were sequenced (47 
inputs and 47 ChIPs). The data obtained were subjected to sequence duplicate removal and 
were subsequently aligned to the Tb427v9.2 genome (Müller et al., 2018). The ChIP data was 
then normalised to input data and visualised in a genome browser. Previously published ChIP-
seq data for H2AZ (Wedel et al., 2017) was used for comparison. The results showed that 8 
proteins are concentrated at RNAPII TSRs, as marked by H2AZ histones (Figure 4.1A), 
whereas the other 13 proteins tested did not show enrichment at specific regions across the 
genome (Figure 4.1B). The 8 positive proteins did not display peaks at any other locations 
including the active VSG-2 ES or the silent VSG ESs.  H2AZ ChIP-seq data showed 
enrichment not only at RNAPII TSRs but also over 7 out of the 11 megabase chromosome 
centromeres. However, no input data was available to normalise the H2AZ ChIP to, so 
enrichment over repetitive centromeric regions could represent an experimental artefact. 





Figure 4.1 Candidate protein enrichment at RNAPII TSRs. The figure shows an 80 kb 
region on chromosome 1 encompassing a centromere and two TSRs (dTSS – divergent TSS; 
sTSS – single TSS). Only a single ChIP-seq replicate for each protein is shown. Each track 
was scaled separately to the highest peak summit (shown as a number in the top left corner 
of each track) in order to demonstrate the peak shapes better.   
(A) Candidate proteins with peaks at RNAPII TSRs marked by H2AZ histones. H2AZ data 
from Wedel et al (2017) was used.  
(B) Candidate proteins with no enrichment in the same region. The kinetochore protein KKT2 




4.3 Analysis of the candidate protein enrichment profiles  
Although many of the candidate proteins analysed were concentrated at RNAPII TSRs, their 
enrichment profiles differed. Chromo1, SET27 and BDF4 displayed sharp peak profiles 
whereas BDF2, Znf-CW1, SET26, HDAC1 and HDAC3 were broadly enriched. These trends 
were analysed bioinformatically using Chromo1 as a reference (Figure 4.2). 177 Chromo1 
peaks were called using MACS2 (Feng et al., 2012) combined with manual filtering of the false 
positives. Protein enrichment was then plotted in 50 bp windows 10 kb upstream and 10 kb 
downstream of the peak summits. The general peak profile for each protein was represented 
as a metagene plot whereas the enrichment around individual Chromo1 peaks was shown as 
a heatmap (Figure 4.3). The results of the analysis showed that Chromo1, SET27 and BDF4 
have sharp peaks at all locations whereas the other candidates consistently displayed a broad 
enrichment around Chromo1.  
The metagene plots in Figure 4.3 were generated by summing the reads around all Chromo1 
peak summits, normalising them to library size and input and representing them as a density 
plot. Thus, more prominent peaks had a higher contribution to the metagene plot than less 
prominent ones. Average metagene plots were also generated by averaging the reads in each 
of the 50 bp windows before plotting them as a density around Chromo1 (Figure 4.4). The 
average metagene plots showed the same trends as seen in Figure 4.3 but were noisier 




Figure 4.2. ChIP-seq analysis strategy. Chromo1 peak summits were called using MACS2 
combined with manual filtering of the false positive calls. The 20 kb region around each summit 
was divided into 50 bp windows. For each candidate analysed, the reads in each window were 




Figure 4.3 Enrichment profile analysis. For each protein, read density around all Chromo1 
peaks was added and represented as a metagene plot whereas read density around individual 
Chromo1 peaks was shown as a heatmap. Going from top to bottom, each heatmap is 
showing enrichment around the 177 Chromo1 peaks in the same order. The scale bars at the 





Figure 4.4 Average metagene plots. For each protein, reads in each 50 bp window around 
Chromo1 peak summits were added up and averaged before plotting as a density.  
 
The candidate proteins that produced broad peaks at transcription start regions appeared to 
have enrichment in a specific direction around each Chromo1 peak summit. To investigate 
this further, the SET26 heatmap was sorted by directionality of its enrichment: the top of the 
heatmap shows enrichment in a 5′ direction, the middle – enrichment in both directions, and 
the bottom – enrichment in a 3′ direction from Chromo1 (Figure 4.5).  The middle portion of 
the heatmap represents two types of profile – enrichment in both directions from a single 
Chromo1 peak or enrichment in opposite directions from two nearby Chromo1 peaks. The 





Figure 4.5 Heatmap sorting. The SET26 heatmap was sorted according to the direction of 
enrichment around Chromo1 peak summits. The panels on the right show example peaks 
from each region of the heatmap. All other heatmaps in Figure 4.3 are sorted according to 
SET26. 
(A) Enrichment in a 5′ direction from Chromo1. 
(B) Enrichment in both directions from Chromo1.  




The heatmaps of the proteins with broad peaks showed identical patterns with respect to the 
direction of enrichment around Chromo1. This suggested that the direction of candidate 
enrichment might be correlated with the direction of RNAPII transcription. To address this, 
available RNA-seq data for slender form parasites (Naguleswaran et al., 2018) was analysed. 
The RNA reads were separated into those originating from the plus and the minus strand of 
DNA. The resulting data was plotted as heatmaps analogously to the candidate proteins 
(Figure 4.6). This revealed that the top part of the heatmaps represents two TSRs directing 
transcription along the minus stand of DNA (Figure 4.6A). Conversely, the bottom part of the 
heatmap represents two TSRs directing transcription along the plus strand of DNA (Figure 
4.6B). The middle of the heatmaps represents two scenarios: a bi-directional TSR or two 
nearby TSRs that direct transcription in opposite directions on opposite DNA strands (Figure 
4.6C).  Overall, this analysis showed that the direction of enrichment of the candidates with 
broad peaks is indeed correlated with the direction of RNAPII transcription. 
The enrichment levels of the candidate proteins at RNAPII TSRs were also quantified. 
Candidate protein reads were counted in non-overlapping 2 kb windows around each 
Chromo1 peak summit. In this analysis, Chromo1 peaks were used as a marker for 
transcription region locations. These reads were then normalised to library size and input and 
represented as box plots (Figure 4.7). On average, Chromo1 was the most highly enriched 
protein across RNAPII TSRs. Chromo1 also displayed higher variation in its enrichment 







Figure 4.6 Candidate protein enrichment is correlated with the direction of RNAPII 
transcription. RNA-seq data from Naguleswaran et al. (2018) was used. 
(A) The top part of the heatmaps represents transcription along the minus strand of DNA. 
(B) The middle part of the heatmaps represents transcription going in opposite directions on 
the plus and minus strands of DNA.  





Figure 4.7 Candidate protein reads around RNAPII TSRs. The box plots represent the 
distribution of reads in 2 kb windows around Chromo1 peak summits which were used as 
RNAPII TSR markers. The boxes extend from the 25th to 75th percentiles. The line in each 
box shows the median value. The whiskers extend to the lowest and highest values. 
 
4.4 Chromo1 binding sequence motif search   
Chromo1, SET27 and BDF4 ChIP-seq profiles revealed sharp peaks at transcription start 
regions, which suggested that one or more of these candidate proteins might be recruited to 
specific genomic loci via a DNA sequence motif. To test this hypothesis, MEME Suite Motif 
Discovery software (http://meme-suite.org) was run on DNA sequences underlying Chromo1 
peaks. Two window sizes were used – a 200 bp window encompassing the sequences 
immediately surrounding Chromo1 peak summits and a 1000 bp window including the 
sequences underlying the entire Chromo1 peaks. The highest-scoring motif for the 200 bp 
window was GT-rich (Figure 4.8A) consistent with previously published data about the 
nucleotide composition of trypanosome RNAPII TSRs (Wedel et al., 2017). The highest-
scoring motif for the 1000 bp window was an A-rich sequence (Figure 4.8B). 
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The GT-rich motif was found at 68 sites across the 177 Chromo1 peaks whereas the A-rich 
motif was found at 258 sites. Additionally, the motifs were long and their positions were 
scattered throughout the 200 bp and 1000 bp windows rather than being concentrated 
immediately under the Chromo1 peak summits (Figure 4.8C and D). These observations 
suggest that the sequences found via MEME are not true binding motifs but rather result from 







Figure 4.8 Chromo1 binding motif search.   
(A) Best-scoring motif generated using a 200 bp window around Chromo1 peaks.  
(B) Best-scoring motif generated using a 1000 bp window around Chromo1 peaks.  
(C)  and (D) Rectangles show the positions of the motifs from A and B, respectively, for five 
Chromo1 peaks. The dashed lines in the middle of the 200 bp and 1000 bp windows indicate 




ChIP-seq analysis of the nuclear and nuclear and cytoplasmic candidate proteins as well as 
Ago1 showed that 8 of them interact with chromatin. These included the putative histone 
methyl mark readers Chromo1 and Znf-CW1, acetyl mark readers BDF2 and BDF4, methyl 
mark writers SET26 and SET27 and acetyl mark erasers HDAC1 and HDAC3. Surprisingly, 
these proteins were always found together at RNAPII TSRs and at no other locations.  
Chromo1, SET27 and BDF4 always displayed sharp peak profiles whereas the other proteins 
were consistently broadly enriched over all RNAPII transcription start regions. These distinct 
groupings suggest that the two sets of candidate proteins may be performing two different 
functions. Potentially, the proteins with sharp peaks are involved in RNAPII recruitment at 
specific genomic loci whereas the other proteins may play a role in transcription initiation or 
the early stages of transcription elongation. Evidence supporting the latter possibility came 
from analysis of available RNA-seq data which showed that the direction of enrichment of the 
candidate proteins with broad peaks is correlated with the direction of RNAPII transcription. 
While H2AZ and H2BV histones as well as the H3K4me3 mark are distributed broadly 
throughout TSR regions, some of the putative chromatin regulators had sharp peaks in these 
locations, suggesting that these proteins might be recruited via DNA sequence motifs rather 
than histone binding. The search for a Chromo1 binding motif yielded a GT-rich and an A-rich 
sequence depending on the window length used. However, these sequences were distributed 
randomly and only under some Chromo1 peaks as opposed to being concentrated under all 
Chromo1 summits. These observations suggest that there is a not a real DNA motif but rather 
a preference for certain nucleotide sequences where Chromo1 binds.  
Overall, in this Chapter, the list of candidate proteins potentially involved in trypanosome 
chromatin organisation was narrowed down further to 8 proteins, none of which were found to 




Identification of protein interaction networks of the TSR-associated 
factors 
5.1 Introduction 
In Chapter 4, eight proteins were found to associate with RNAPII TSRs, however their role in 
RNAPII-directed transcription remains to be determined. The two distinct ChIP-seq profiles 
observed (sharp and broad) suggested that these proteins are performing at least two different 
functions, possibly related to transcription initiation and elongation. It is also possible that 
these TSR-associated factors might act as transcriptional activators or repressors. For 
example, Bromo-domain proteins are normally associated with actively transcribed regions 
whereas HDACs contribute to transcriptional repression. These two possibilities could not be 
distinguished based on the ChIP-seq data alone. Thus, the approach taken was affinity 
purification coupled with mass spectrometry in order to further characterise the candidate 
proteins and to get an indication of what their functions might be. All protein affinity selections 









5.2 Chromo1 and SET27 display strong reciprocal interaction with each other  
Affinity purification of YFP-Chromo1 and YFP-SET27 followed by liquid chromatography with 
tandem mass spectrometry (LC-MS/MS) showed that they interact strongly with each other, 
with a common set of four uncharacterised proteins (designated in this thesis as UP1-4) and 
the J biosynthesis protein JBP2 (Figure 5.1). This suggested that Chromo1 and SET27 may 
be part of the same protein complex which is described in more detail in Chapter 6. 
Additionally, Chromo1 co-purified with two RNAPII subunits (RPB1 and RPB3), transcription 
elongation factor s-II (TFIIS2-1) and repressor activator protein 1 (RAP1) which is involved in 
VSG silencing (Yang et al., 2009a). The SET27 affinity purification also contained TFIIS2-1, 
the cohesin subunit SMC3 (Bessat and Ersfeld, 2009a) and JBP1 which, in addition to JBP2, 
is involved in the synthesis of base J.  The absence of significantly enriched histones in these 
preparations suggests that the interaction between Chromo1, SET27 and the other five 
putative complex members is not mediated by chromatin. The full list of significantly enriched 









Figure 5.1 Chromo1 and SET27 co-purify each other in bloodstream form parasites.  
(A) YFP-Chromo1 IP 
(B) YFP-SET27 IP 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 




5.3 Znf-CW1 and SET26 display strong reciprocal interaction with each other  
Affinity purification of YFP-Znf-CW1 and YFP-SET26 followed by LC-MS/MS showed that 
these proteins interact strongly with each other. The presence of many histones and histone 
variants in these preparations indicates that this protein interaction might be indirect and 
mediated by chromatin. The FACT complex subunits spt16 and POB3 as well as the Bromo-
domain factor BDF7 were also found in the two preparations. Additionally, both affinity 
purifications contained importins and the nucleoporin NUP59.  
Actin and actin-related proteins, ruv-B and SWI/SNF helicases, BDF2 and BDF5 co-purified 
with Znf-CW1 only whereas three RNAPII subunits (RPB1, RPB2 and RPB3) were significantly 




Figure 5.2 Znf-CW1 and SET26 co-purify each other in bloodstream form parasites.  
(A) YFP-Znf-CW1 IP 
(B) YFP-SET26 IP 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 




5.4 BDF2 and HDAC3 display strong reciprocal interaction with each other  
Affinity purification of YFP-BDF2 and YFP-HDAC3 coupled with LC-MS/MS showed that they 
interact strongly with each other. The telomere factors TRF, TRF-interacting factor 2 (TIF2) 
and telomere-associated protein 1 (TelAP1) as well as the TSR-associated histone variants 
H2AZ and H2BV and the microhomology-mediated end-joining DNA polymerase theta 
(POLQ) were enriched in both affinity purifications.  
Two class I transcription factors A (CITFA-1 and CITFA-4) co-purified only with BDF2 whereas 
RAP1 and the cohesin subunits SMC1 and SMC3 were found only in the HDAC3 preparation. 
The BDF2 interaction with Znf-CW1 seen in section 5.3 was also confirmed and could explain 






Figure 5.3 BDF2 and HDAC3 co-purify each other in bloodstream form parasites.  
(A) YFP-BDF2 IP 
(B) YFP-HDAC3 IP 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 




5.5 BDF4 and BDF1 display strong reciprocal interaction with each other 
Affinity purification of BDF4 coupled with LC-MS/MS showed that BDF4 interacts strongly 
with BDF1 and to a lesser degree with two other Bromo-domain proteins (BDF3 and BDF5).  
 
 
Figure 5.4 YFP-BDF4 IP. 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 








5.6 HDAC1 does not interact with other candidate proteins 
No other candidate proteins co-purified with YFP-HDAC1. Significantly enriched in this 
preparation were four uncharacterised proteins and a valosin-containing protein homolog. 
 
 
Figure 5.5 YFP-HDAC1 IP. 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 









Chromo1 and SET27 were found to strongly associate with each other and are likely part of 
the same protein complex (described in more detail in Chapter 6) together with JBP2 and 4 
uncharacterised proteins. The presence of JBP2 was surprising because it is involved in the 
synthesis of base J which is found at telomeres and TTRs as opposed to transcription start 
regions (Schulz et al., 2016). 
Znf-CW1 and SET26 were also found to associate strongly with each other. The presence of 
many histones and histone variants in these affinity purifications indicates that this protein-
protein interaction, unlike the Chromo1-SET27 interaction, may be mediated by chromatin. 
Additionally, the enrichment of importins and the nucleoporin NUP59 in these preparations 
suggests possible association with the nuclear transport machinery. BDF7 as well as the two 
subunits of the FACT complex, POB3 and spt16, also co-purified with both Znf-CW1 and 
SET26. The FACT complex is known to facilitate RNAPII transcription elongation by acting as 
a histone chaperone that destabilises nucleosome structure in front of the transcribing 
polymerase and restores it behind (Belotserkovskaya, 2003; Formosa et al., 2002; Saunders, 
2003). SET26 but not Znf-CW1 was found to associate with three RNAPII subunits whereas 
Znf-CW1 but not SET26 co-purified with Bromo-domain proteins BDF2 and BDF5, ruvB and 
SWI/SNF helicases as well as actin and actin-related proteins. In budding yeast, the SWI/SNF 
chromatin remodeller has been described as a transcriptional  activator that works by 
destabilising nucleosomes and thus promoting an open chromatin structure (Hirschhorn et al., 
1992). Actin and actin-related proteins have been identified as subunits of the SWI/SNF 
complex (Hargreaves and Crabtree, 2011). RuvB helicase is an ATPase that is involved in 
homologous recombination in bacteria (West, 2003). In eukaryotes, ruvB has been described 
as a chromatin decondenser (Magalska et al., 2014) and is also known as part of the SWR1 
and INO80 chromatin remodeller complexes both of which also contain actin-related proteins 
(Bao and Shen, 2011). SWR1 facilitates the exchange of canonical H2A for the less stable 
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H2AZ histones found at TSRs and can thus act as a transcriptional activator whereas INO80 
can regulate transcription positively or negatively. These data indicate that Znf-CW1 and 
SET26 interact with and possibly target transcriptional activators and repressors to TSR 
regions. 
BDF2 and HDAC3 were found to associate strongly with each other as well as with three 
telomeric factors, consistent with the role of HDAC3 in silencing of ES-VSGs which are located 
in subtelomeric regions on the megabase and intermediate chromosomes (Wang et al., 2010). 
Additionally, HDAC3 co-purified with RAP1 which is also known to be an ES silencing factor 
(Yang et al., 2009b). The TSR-associated histone variants H2AZ and H2BV were also 
enriched in both preparations, indicating that the BDF2-HDAC3 interaction may be indirect. 
The BDF2 affinity purification confirmed the interaction with Znf-CW1 and its associated 
proteins (SWI/SNF, ruvB and actin). Interestingly, BDF2 also co-purified with two RNAPI 
transcription factors (CITFA-1 and CITFA-4) (Brandenburg et al., 2007), providing further 
evidence for the association of HDAC3 and BDF2 with VSG expression. 
Finally, BDF4 was found to associate strongly with BDF1 but less strongly with BDF3 and 
BDF5 whereas HDAC1 did not show interactions with other candidate proteins. 
Overall, the affinity selection experiments described in this Chapter showed that although 8 
candidate proteins were enriched at RNAPII TSRs, they form distinct protein interaction 
networks. These networks gave indication of what putative complexes these TSR factors 







Characterisation of the putative Chromo1/SET27 complex in 
bloodstream and procyclic form parasites 
6.1 Introduction 
The results of the affinity selection experiments presented in Chapter 5 suggested that the 
association between Chromo1 and SET27 may occur in the context of a protein complex. The 
reason for this is two-fold. First, in both YFP-Chromo1 and YFP-SET27 purifications the same 
7 proteins were most highly enriched in all of the replicate experiments, and second, the 
absence of histones in these preparations indicates that the interactions between the 7 
proteins are not mediated by chromatin. Additionally, the ChIP-seq data from Chapter 4 
showed that Chromo1 and SET27 had the same sharp peak profiles at TSRs in contrast to 
most of the candidate proteins which were broadly enriched in these regions. However, BDF4, 
which also displayed a very focused enrichment at TSRs, did not co-purify with Chromo1 and 
SET27.  
The aim of the experiments presented in this Chapter was to characterise the composition of 
the putative protein complex in BF and PF parasites and to gain an insight into its function, 






6.2 Domain composition, cellular localisation and genomic association of the 
putative complex members 
Chromo1 and SET27 were part of the initial screen for putative readers, writers and erasers 
of trypanosome histone PTMs because of their predicted protein domains (Chapter 3). 
Homology models of these domains by Dr Jeyaprakash Arulanandam showed that the single 
Chromo domain of Chromo1 is lacking three key aromatic residues important for binding of 
histone methyl marks (Figure 6.1A) whereas the single SET domain of SET27 is very similar 
to the SET domain found in a human H3K4 monomethyltransferase (Figure 6.1B). Analysis of 
the amino acid sequence of the uncharacterised proteins showed that UP3 has a weakly 
predicted Chromo domain whereas UP4 has a weakly predicted FYVE/PHD zinc finger 
domain, both domains being found in histone methyl mark readers. JBP2 was found to contain 
a DEAD-box helicase domain. The analysis did not yield information about protein domains in 
UP1 and UP2.  
UP1-4 and JBP2 were YFP-tagged and immunolocalised in BF cells (Figure 6.2) utilising the 
same strategy as in the initial screen (Chapter 3). UP1-4 were found to be nuclear with dotted 
appearance whereas JBP2 was both nuclear and cytoplasmic. 
To assess whether the putative protein complex has the same composition during the insect 
stage of T. brucei’s life cycle, Chromo1, SET27 and JBP2 were also YFP-tagged in the 
procyclic form. JBP2 was expressed at approximately the same level in both BF and PF cells 
(Appendix C) in contrast to previous studies in which JBP2 was found to be absent in PF 
parasites (Borst and Sabatini, 2008). Microscopy imaging without antibody staining showed 
that in the PF Chromo1 and SET27 are nuclear whereas JBP2 is cytoplasmic (Figure 6.3). In 
the TrypTag project, UP1 was found to be mitochondrial when tagged N-terminally and nuclear 




ChIP-seq of Chromo1 tagged in the procyclic form showed sharp peaks at TSR regions, 
analogously to the results obtained in the bloodstream form (Figure 6.4). None of the 7 
proteins were found to be essential in an RNAi screen (Alsford et al., 2011). Thus, in this 
project it was attempted to generate Chromo1 and SET27 knockouts in BF cells via CRISPR. 
However only a single allele of each protein could be knocked out, suggesting that Chromo1 
and SET27 are essential in the bloodstream form. Table 6.1 summarises the available 




Figure 6.1 Homology models of Chromo1 and SET27 domains. 
(A) The Chromo domain of Chromo1 (orange) was modelled to the Chromo domain of Chp1 
(green). Note that the T. brucei Chromo1 lacks the three aromatic residues necessary for 
binding of methylated lysines. 
(B) The SET domain of SET27 was modelled to SET7/9 (H3K4 monomethyltransferase). 




Figure 6.2 Immunolocalisation of UP1-4 and JBP2 in BF parasites. Immunolocalisation 
was performed using an anti-GFP primary and a red fluorescently labelled secondary 





Figure 6.3 Localisation of Chromo1, SET27 and JBP2 in PF parasites. Proteins were 
localised via direct visualisation of the YFP tag without antibody staining. Nuclear and 









Figure 6.4 Chromo1 enrichment at RNAPII TSRs in BF and PF parasites.  
(A) BF and PF Chromo1 enrichment over a 350 kb region on chromosome 1. Each track is 
scaled separately to the highest peak summit (shown as a number in the top left corner of 
each track) in order to demonstrate the peak shapes better.   








6.3 Complex composition in the bloodstream and procyclic form 
Affinity selection of the tagged putative complex members in the bloodstream form showed 
that they all co-purify with each other. Additionally, they were the most enriched proteins in 5 
out of the 7 affinity selections, as shown by their clustering in the top right corner of volcano 
plots (Figure 6.5).  
UP2 and UP4 preparations had similar composition – both proteins co-purified with JBP1, 
NUP59, FACT complex subunits (spt16 and POB3), RNAPII subunits (RPBs), cohesin 
subunits (SMC1 and SMC3) as well as multiple histones and kinetochore proteins (KKTs).  
UP1 co-purified with NUP59 as well as with a single histone (H4V) and a single kinetochore 
protein (KKT3), both of which were highly enriched in the UP2 and UP4 experiments. 
A nucleolus protein (Tb927.10.3220) was enriched in the Chromo1, SET27, UP3 and JBP2 
purifications. Additionally, one uncharacterised protein (Tb927.10.3070) was found to 
associate with SET27, UP3 and JBP2 whereas a second uncharacterised protein 










Figure 6.5 Affinity purification of the putative complex members in BF parasites. 
(A) YFP-Chromo1 IP (panel copied from Figure 5.1) 
(B) YFP-SET27 IP (panel copied from Figure 5.1) 
(C) YFP-JBP2 IP 
(D) YFP-UP1 IP 
(E) YFP-UP2 IP 
(F) YFP-UP3 IP 
(G) YFP-UP4 IP 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 














YFP-Chromo1, YFP-SET27 and YFP-JBP2 were affinity purified from PF cells in order to 
identify their protein interactors at this developmental stage of T. brucei (Figure 6.6). Chromo1 
co-purified with all putative complex members except JBP2. In contrast, Chromo1, along with 
SET27, UP1 and UP2, was significantly enriched in the JBP2 experiment. UP3 and UP4 were 
completely absent from the JBP2 preparation (they were not identified even among the 
nonsignificant proteins). SET27 was found to associate with all the other putative complex 
members, with JBP2 being significantly less enriched than the rest. Additionally, Chromo1 and 
SET27 co-purified with the RNAPII-associated protein LEO1 and the kinetochore-interacting 










Figure 6.6 Affinity purification of the putative complex members in PF parasites. 
(A) YFP-Chromo1 IP  
(B) YFP-SET27 IP  
(C) YFP-JBP2 IP 
Cut-offs used for significance: p < 0.01 and log2 (tagged/untagged) > 2 or < -2. Significantly 








Mass spectrometry data presented in this Chapter provided further evidence supporting the 
idea that Chromo1 and SET27 form a complex together with UP1-4 and JBP2 in bloodstream 
form parasites. The absence of key residues necessary for histone methyl mark binding in the 
Chromo1 homology model indicates that it might not interact directly with histones. Instead, 
UP3 and/or UP4 might bind methylated histones owing to a weakly predicted Chromo and 
FYVE/PHD zinc finger domain, respectively, in their amino acid sequence. Additionally, the 
presence of multiple histones and histone variants in the UP2 and UP4 affinity selections 
suggests that these proteins might be the chromatin-interacting members of the complex. The 
similarity of SET27 to an H3K4 methyltransferase is consistent with the presence of H3K4me3 
at trypanosome TSRs (Wright et al., 2010). The enrichment of RNAPII and FACT complex 
subunits in the UP2 and UP4 affinity purifications indicates potential involvement in RNAPII 
transcription regulation. Surprisingly, UP2 and UP4 also co-purified with multiple kinetochore 
proteins, and thus it would be interesting to investigate via ChIP-seq whether UP2 and UP4 
associate with centromeric regions which are known to be transcribed in other eukaryotes 
(Djupedal et al., 2005; Saffery et al., 2003). The YFP-JBP2 affinity selection differed from the 
others in that the putative complex members did not cluster together in the top right corner of 
the volcano plot, suggesting that JBP2 may be a facultative subunit of this complex. 
Mass spectrometry data from procyclic form parasites showed that JBP2 is weakly associated 
with only 4 of the other complex members. This is consistent with the changes in protein 
localisation observed: in the bloodstream form JBP2 and SET27 are nuclear and cytoplasmic 
whereas in the procyclic form SET27 is exclusively nuclear and JBP2 is found only in the 
cytoplasm. Although the putative complex has different composition in BF and PF cells, its 
function might be conserved during trypanosome development, as indicated by the identical 





The ability to survive various environmental conditions, progress through development and, in 
the case of multicellular organisms, form tissues, organs and systems specialised to perform 
different functions relies on precise regulation of gene expression. In eukaryotes, DNA exists 
in the context of chromatin, the latter functioning to make DNA more or less accessible to the 
transcription machinery, thus providing the first level of gene expression control. Gene 
activation and repression are influenced by largely conserved chemical modifications on DNA 
and histone proteins. However, as one of the earliest-branching eukaryotes, T. brucei 
represents a divergent system for the study of gene expression. Thus, by identifying the 
similarities and differences in the mechanisms for gene expression control between T. brucei 
and commonly studied model organisms within the Opisthokonta supergroup, both gene 
regulation principles fundamental to eukaryotes and specific to a particular supergroup could 
be uncovered. This study aimed to characterise proteins potentially involved in the deposition, 
binding or removal of trypanosome histone acetyl and methyl PTMs which are known to be 
important for chromatin organisation in other eukaryotes. However, it should be noted that the 
regulation of trypanosome chromatin may depend on different histone modifications which 
have not been investigated in this study. 
In the first stage of the project, 34 candidate proteins were fluorescently tagged and 
immunolocalised in bloodstream form parasites. The localisations observed were largely 
consistent with data on procyclic cells from the TrypTag project (Dean et al., 2017). One 
surprising finding from the screen was that most of the 30 SET-domain candidate proteins 
were exclusively cytoplasmic, suggesting that they might methylate non-histone substrates, 
such as tubulin which is known to be modified by a histone methyltransferase that links 
chromatin and cytoskeletal organisation (Park et al., 2016). Alternatively, the cytoplasmic 
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SET-domain proteins might be secreted and act on host molecules, reminiscent of the 
mechanism by which many pathogens modulate their host activity, including chromatin 
organisation and gene expression (Silmon De Monerri and Kim, 2014). 
Chromatin immunoprecipitation and sequencing of the nuclear and nuclear and cytoplasmic 
candidate proteins showed that 8 of them associate with RNAPII TSRs and none are enriched 
over other genomic regions. Analysis of the ChIP-seq profiles with respect to Chromo1 
showed that Chromo1, SET27 and BDF4 have focused enrichment at all TSRs whereas 
SET26, BDF2, Znf-CW1, HDAC1 and HDAC3 are consistently broadly distributed around 
Chromo1. This observation suggests that these proteins perform at least two different 
functions at TSRs, possibly related to transcription initiation or elongation. The distribution of 
the broadly enriched proteins was correlated with the direction of RNAPII transcription, 
suggesting that they might travel for a short distance with the elongating polymerase before 
falling off.  Among the identified TSR factors, some are expected to activate and others – to 
repress transcription. For example, BDF2 and BDF4 are putative Bromo-domain readers of 
acetylated histones, the latter being loosely associated with DNA and consequently found at 
transcriptionally active regions (Hebbes et al., 1988; Ridsdale et al., 1990). Conversely, 
HDAC1 and HDAC3 are putative erasers of histone acetyl modifications and are therefore 
likely to be associated with transcriptionally repressive chromatin. Since acetylation physically 
disrupts the electrostatic attraction between DNA and histones, the roles of BDFs and HDACs 
in chromatin organisation are likely to be conserved between T. brucei and other eukaryotes. 
Although the 8 TSR-enriched proteins were always found together, it cannot be concluded 
that this is true for individual parasites based on the ChIP-seq data obtained from cell 
populations. Exploring the possibility that different cells have a different combination of the 
candidate proteins in association with different TSRs would require optimisation of single-cell 
ChIP-seq methodology in T. brucei. 
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The effect of the candidate proteins on transcription could be tested by measuring the level of 
newly synthesised transcripts upon depleting or knocking out the TSR-associated factors. 
Nascent RNA-seq as opposed to steady-state RNA-seq should be used in order to avoid 
interference from post-transcriptional gene regulation mechanisms. The results interpretation 
following such knock out or knock down experiments could be complicated if the candidate 
proteins are essential, which was found to be the case for Chromo1 and SET27. Additionally, 
removal of a single protein from TSRs might not have an effect on transcription if there is 
redundancy of function among the TSR-associated proteins, and combinatorial experiments 
might be required instead. 
Interaction partners of the TSR-associated factors were identified via affinity purifications 
followed by mass spectrometry. These experiments showed that although many candidate 
proteins are enriched over the same genomic regions, they do not all interact with each other 
and are likely part of different protein complexes that perform distinct functions at RNAPII 
TSRs.  The putative complex identified with highest confidence was that of Chromo1 and 
SET27 with UP1-4 and JBP2. Both Chromo1 and SET27 displayed sharp peak profiles at 
TSRs in contrast to the other candidate proteins, and it would be interesting to investigate 
whether that is also the case for UP1-4 and JBP2. However, BDF4, which also had focused 
enrichment at TSRs, was not identified as an interacting partner of Chromo1 and SET27. 
Two outstanding questions are how the putative Chromo1/SET27 complex is recruited to TSR 
regions and what its function is, particularly in relation to RNAPII transcription. No DNA 
sequence binding motif was identified for Chromo1, the location of which is coincident with 
SET27, so it is unlikely that the putative complex is recruited to TSRs via interaction with DNA. 
The other two possibilities are recruitment via binding to histones or other TSR-associated 
proteins. Chromo1, UP3 and UP4 have weakly predicted methyl mark binding domains in their 
amino acid sequences whereas the SET domain of SET27 was found to bear similarity to the 
SET domain of an H3K4 monomethyltransferase. These observations indicate that the 
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putative complex might contain several readers and a writer of a histone methyl PTM, such as 
the H3K4me3 mark which, analogously to other eukaryotes, is found at trypanosome TSRs 
(Wright et al., 2010). The SET domain of SET27 contains a tyrosine residue predicted to exert 
steric hindrance that would prevent the addition of more than one methyl group on histone 
lysines. Thus, if SET27 indeed methylates H3K4, it is unclear which methyltransferase(s) 
write(s) the di- and tri- methyl marks on that residue. In vitro methyltransferase assays using 
recombinant SET27 and synthetic H3K4me0, H3K4me1 and H3K4me2 peptides performed 
by Dr Sharon White gave a negative result (none of the peptide residues were methylated by 
SET27). However, multiple variables of the in vitro assays might require optimisation, including 
expression of recombinant protein from eukaryotic as opposed to bacterial cells and presence 
of other members of the complex. A more unbiased approach would be to purify the entire 
protein complex from trypanosome cells and attempt the in vitro methyltransferase assay with 
recombinant T. brucei nucleosomes. However, this methodology might be unsuccessful due 
to insufficient amount and/or insufficient purity of the protein complex.   
The function of the putative Chromo1/SET27 complex at RNAPII TSRs is of particular interest 
because of the apparent dominance of post-transcriptional gene regulation mechanisms in T. 
brucei. This could be investigated by measuring the levels of newly synthesised transcripts in 
the absence of one or more of the 7 putative complex members.  Chromo1 and SET27 were 
found to be essential which could be because they perform an important function or because 
their absence disrupts the integrity of the protein complex. Thus, knock downs of Chromo1 
and SET27 or knock outs of other members of the complex, provided they are non-essential, 
could be utilised.  
The presence of JBP2 in the TSR-associated complex was surprising because JBP2 is 
involved in the synthesis of the TTR marker base J. This suggests the interesting possibility 
that the function of the Chromo1/SET27 complex might be to terminate antisense transcripts, 
analogously to other eukaryotes where most TSRs are bi-directional but antisense transcripts 
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originating from those are rapidly degraded (Bresson and Tollervey, 2018). However, many 
TSRs in T. brucei generate stable transcripts in both directions, so it is unclear how the 
Chromo1/SET27 complex would terminate antisense transcripts from uni- but not from bi-
directional TSRs. It is also possible that the function of JBP2 at RNAPII TSRs is independent 
of its role in base J synthesis.  
Overall, the work presented in this thesis identified novel proteins associated with 
trypanosome RNAPII TSRs and initiated their characterisation. The presence of multiple 
factors near transcription start sites supports the idea of a complex regulatory landscape 
where transcriptional control is likely to play an important role alongside post-transcriptional 
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One bottle of HMI-9 powder (Life technologies) 
45mM NaHCO3 
256μM β-mercaptoethanol 
up to 4 litres with autoclaved dH2O 
pH 7.5 
The medium was filtered through a 0.22μm filter. 
Before use, the media was supplemented with 10% heat-inactivated FCS (Gibco), 100U/ml 





1 bottle of SDM-79 powder (Life technologies)  
9g NaHCO3 
4.5 litres of autoclaved dH2O 
pH 7.3  
The medium was filtered through a 0.22μm filter. 
Before use, the media was supplemented with 10% heat-inactivated FCS (Gibco), 100U/ml 






1X PBS pH 7.4 
Component Concentration 
NaCl 137 mM 
KCl 2.7 mM 
Na2HPO4 10 mM 
KH2PO4 1.8 mM 
 
 
Mowiol + DABCO 
Component Concentration 
Mowiol 4-88 reagent (Calbiochem) 10% (w/v) 
Glycerol 25% (v/v) 
Tris-HCl pH 8.5 100 mM 




Homemade transfection buffer (Burkard et al., 2011) 
Component Concentration 
NaPO4    90 mM 
KCl 5 mM 
CaCl2 0.15 mM 












HEPES-KOH pH 7.5 50 mM 
NaCl 100 mM 
EDTA 1 mM 
EGTA 0.5 mM 
Formaldehyde 8% (v/v) 
 
 
Lysis buffer 1 
Component Concentration 
HEPES-KOH pH 7.5 50 mM 
NaCl 140 mM 
EDTA 1 mM 
Glycerol 10% (v/v) 
NP-40 0.5 % (v/v) 
Triton X-100 0.25% (v/v) 
 
 
Lysis buffer 2 
Component Concentration 
Tris-HCl pH 8.0 10 mM 
NaCl 200 mM 
EDTA 1 mM 
EGTA 0.5 mM 
126 
 
Lysis buffer 3 
Component Concentration 
HEPES-KOH pH 7.5 50 mM 
NaCl 140 mM 
EDTA 1 mM 
Triton X-100 1% (v/v) 
sodium deoxycholate            0.1% (v/v) 
 
 
Wash buffer 1 
Component Concentration 
HEPES-KOH pH 7.5 50 mM 
NaCl 500 mM 
EDTA 1 mM 
Triton X-100 1% (v/v) 
sodium deoxycholate            0.1% (w/v) 
 
 
Wash buffer 2 
Component Concentration 
Tris-HCl pH 8.0 10 mM 
LiCl 250 mM 
NP-40 0.5% (v/v) 
sodium deoxycholate            0.5% (w/v) 








Tris-HCl pH 8.0 10 mM 





Tris-HCl pH 8.0 50 mM 
EDTA 10 mM 
SDS 1% (v/v) 
 
 
III. Protein IPs  
 
Lysis buffer MS 
Component Concentration 
Tris-HCl pH 8.0 50 mM 
KCl 150 mM 
NP-40 0.2% (v/v) 
 
 
Borate buffer pH 9.0 
Component Concentration 
Boric acid 40 mM 




ABC buffer pH 8.0 
Component Concentration 







Tris 89 mM 
Acetic acid 89 mM 
EDTA 2 mM 
 
 
TAE buffer  
Component Concentration 
Tris 40 mM 
Acetic acid 20 mM 





Tryptone 10 g 
Yeast extract 5 g 
NaCl 10 g 




Primers used in this study 
“F” denotes a forward primer, whereas “R” indicates a reverse primer. 
 
Lowercase sequences align to plasmid DNA, whereas upper case sequences align to 
trypanosome DNA. 
 
I. N-terminal YFP tagging 
Primer name Sequence 
blast-eYFP F gtataatgcagacctgctgc 
blast eYFP R actacccgatcctgatcc 
Chromo1 CDS F ggatcaggatcgggtagtATGTCCATCCACCAAACAAAAGTC 
Chromo1 CDS R TGACCACTCTCCCAAGCCTA 
Chromo1 5′UTR F GATGTATGGCGCAGAAGGGT 
Chromo1 5′UTR R gcagcaggtctgcattatacGAGTTCCGGTTGCAACTGATTG 
PHD12 CDS F ggatcaggatcgggtagtATGAAGTTTGAGAACCCCGTTG 
PHD12 CDS R TTCTCGGTCGGCATTGGAAA 
PHD12 5′UTR F ACGAGCGGGTTTAGTGAAGG 
PHD12 5′UTR R gcagcaggtctgcattatacCGGTGTGCCTGTGTGATAAA 
PHD13 CDS F ggatcaggatcgggtagtATGAGCACATCCCTCACGTC 
PHD13 CDS R GCACGACTTTCACCACGTTC 
PHD13 5′UTR F ACCCTCTTCAATGCACTCCG 
PHD13 5′UTR R gcagcaggtctgcattatacTGCAGACTACGGCAAAAGGA 
PWWP1 CDS F ggatcaggatcgggtagtATGATTCCATCATTTGCTCCAGG 
PWWP1 CDS R CCTTCGTCTTCTTTCCGCCT 
PWWP1 5′UTR F GGGCGTAATAACGAGGTGGA 
PWWP1 5′UTR R gcagcaggtctgcattatacTTTTTTTCTTTTCCCCCCGTGG 
130 
 
Primer name Sequence 
Tudor CDS F ggatcaggatcgggtagtATGTCTTTTCTTGTGTATGCCG 
Tudor CDS R AGTAACCTGTGCATCGCCAA 
Tudor 5′UTR F CTTATCGGCTGCTTTCGCAC 
Tudor 5′UTR R gcagcaggtctgcattatacTTGAGTATGTCCTCTGTTACCCC 
Znf-CW1 CDS F ggatcaggatcgggtagtATGCTAACTCGAAGAGCCGC 
Znf-CW1 CDS R TCACCTCAGGTTCGCTTTCC 
Znf-CW1 5′UTR F TAACGACACTGCAAATCCCT 
Znf-CW1 5′UTR R gcagcaggtctgcattatacATATATATATATAACAAATATGCACAAC 
BDF2 CDS F ggatcaggatcgggtagtATGAGCAAGAACGAGCGAGATAC 
BDF2 CDS R CGCAGTGTTGATTCGTCGTC 
BDF2 5′UTR F TGTGGATTCAGTGGGTTGGG 
BDF2 5′UTR R gcagcaggtctgcattatacTGCTCTAACGCAGATGTTCG 
BDF4 CDS F ggatcaggatcgggtagtATGTCGGGGGGCACCTC 
BDF4 CDS R AAAACCTCCTCCATCAGCCG 
BDF4 5′UTR F TTACTGGGTTGTGTGAGCGG 
BDF4 5′UTR R gcagcaggtctgcattatacTGTGGAGGGACAACGAAGAG 
SET1 CDS F ggatcaggatcgggtagtATGCAAACAGAAGCCCTGC 
SET1 CDS R AGTAGACCGTGGTAACGGGA 
SET1 5′UTR F ACAGTACCCCGTTTGCTGAG 
SET1 5′UTR R gcagcaggtctgcattatacGCAACCAAAAAAAAAAAGGAGCTAC 
SET2 CDS F ggatcaggatcgggtagtATGGTGAGGCTTCGCTCG 
SET2 CDS R AAGGCTCCTGTTCACTGACG 
SET2 5′UTR F TGAGTCTCCGCATATGGCAC 
SET2 5′UTR R gcagcaggtctgcattatacGCAAGGGCTAACCGACCC 
SET3 CDS F ggatcaggatcgggtagtATGGAGGAGTTGCGTAAACG 
SET3 CDS R TGGCGGCAAAATCTCAGCTA 
SET3 5′UTR F ATTACATGGAGGGGATGCCG 




Primer name Sequence 
SET4 CDS F ggatcaggatcgggtagtATGTCATGGGTGGAAGACAAGTC 
SET4 CDS R TAAGCGTTACGTGAGCCTCG 
SET4 5′UTR F CCACTTTCCCTTAGCCCGAT 
SET4 5′UTR R gcagcaggtctgcattatacCCCAGGTGGGTTGGCAAC 
SET5 CDS F ggatcaggatcgggtagtATGCCGACTCAGAGCCCC 
SET5 CDS R GCCACAAAAGAGCTTCCACG 
SET5 5′UTR F GAGTGTGAGGAACGGAAGCA 
SET5 5′UTR R gcagcaggtctgcattatacCCTTTTCCACTTTCTCCCCC 
SET21 CDS F ggatcaggatcgggtagtATGCTCCAGCAATTATCCGC 
SET21 CDS R GCGTTGTTTCTCTGGCGAAG 
SET21 5′UTR F GATGTGGTCATGCGTGGTTG 
SET21 5′UTR R gcagcaggtctgcattatacAGCCCAATGATACTGGGCC 
SET22 CDS F ggatcaggatcgggtagtATGGCCACTGTCACGGAG 
SET22 CDS R GAGCCAGTTCGTTGGTGAGA 
SET22 5′UTR F CAGCACGCTTCATCCCTACA 
SET22 5′UTR R gcagcaggtctgcattatacTTTTGTTGCCAAATTACGTATGTAC 
SET23 CDS F ggatcaggatcgggtagtATGCCTGGGTGTCTTGAGG 
SET23 CDS R TTCGACAGCACATTCCGTGA 
SET23 5′UTR F TCACTACAAGGCCGGTTGTC 
SET23 5′UTR R gcagcaggtctgcattatacTATCCGGTCATATATATATATATAT 
SET24 CDS F ggatcaggatcgggtagtATGAACAGGGGGTCGGTG 
SET24 CDS R TCTTGAGGTTTTCCCTCGCC 
SET24 5′UTR F GAGGGGAAAGTGCTGCTCAT 
SET24 5′UTR R gcagcaggtctgcattatacTCGCTACGCCTTTCCACC 
SET25 CDS F ggatcaggatcgggtagtATGCCGGCCAAACCCAC 
SET25 CDS R CCAACACTGCTGTAACCGGA 
SET25 5′UTR F GGTGCAAAGGAATGACGGTG 




Primer name Sequence 
SET26 CDS F ggatcaggatcgggtagtATGATATGCAAGGTTTTGGAGCG 
SET26 CDS R TACTCACACATCACGGTGCC 
SET26 5′UTR F GGTTACCCGAAAGCAGTGGA 
SET26 5′UTR R gcagcaggtctgcattatacGCACTGTGGCAACTAATCACG 
SET27 CDS F ggatcaggatcgggtagtATGGATGTGCATTCCCCGTTAC 
SET27 CDS R TCGTTCGCAAACCGACCATA 
SET27 5′UTR F TCTCGACTATGCGGTTCGTG 
SET27 5′UTR R gcagcaggtctgcattatacTCCACACGAGGAAACACTGC 
SET28 CDS F ggatcaggatcgggtagtATGGTAATGAAAGCCAATTTCTGC 
SET28 CDS R TTTGGTTGGCAAGAATGCCG 
SET28 5′UTR F AATGGTTTGCCGGGACATCT 
SET28 5′UTR R gcagcaggtctgcattatacTTCTCCTCGCTCTTAGTTTATCCG 
SET29 CDS F ggatcaggatcgggtagtATGTCTGAGGTGGTACCTACTCG 
SET29 CDS R AAAGCGGCAGGGACTTCTAC 
SET29 5′UTR F TGAGGCGCATGATCCACTTT 
SET29 5′UTR R gcagcaggtctgcattatacACCAACTTGGAGTACAAAGAAGAC 
SET30 CDS F ggatcaggatcgggtagtATGTACAGAATAGCAATTCGACG 
SET30 CDS R TTACCTCCAGGATGAGCGGA 
SET30 5′UTR F CACAATAAGTGCCATGCGGT 
SET30 5′UTR R gcagcaggtctgcattatacCCCTTTTCTTATACTCCTTCACG 
Jmj1 CDS F ggatcaggatcgggtagtATGCTGGAACTGGACGGAC 
Jmj1 CDS R CCCTCCAGCGTTCAATGACT 
Jmj1 5′UTR F ACCAGCATTGGGATCGGTTT 
Jmj1 5′UTR R gcagcaggtctgcattatacAGCCAACAGAAACTTGCAAAAATATATAC 
Jmj2 CDS F ggatcaggatcgggtagtATGGCGCAGAGCTGGTTC 
Jmj2 CDS R CGGACGATGGGACAAGTTCA 
Jmj2 5′UTR F TTGGCTGAAGAGCATGCAGA 




Primer name Sequence 
LCM1 CDS F ggatcaggatcgggtagtATGTCCATTGCGGTAGAAGAGAG 
LCM1 CDS R CTTGGATTGCATAACGGCGG 
LCM1 5′UTR F ATCGAAGACACGACGGCTTT 
LCM1 5′UTR R gcagcaggtctgcattatacTAAGGTGTTTTGTGAGGTAGCAAC 
CLD1 CDS F ggatcaggatcgggtagtATGCCAAATGAAAAGGCGCAG 
CLD1 CDS R TGCATCCGATTCCGTCACAA 
CLD1 5′UTR F GATTTGCTTGGGTGGTGCTG 
CLD1 5′UTR R gcagcaggtctgcattatacCGCATGAACTTCCTGCAGTTTTTG 
HDAC1 CDS F ggatcaggatcgggtagtATGAATGAGGATGGTGATTGTCGG 
HDAC1 CDS R GATGGCCTGTACCCGGAAAA 
HDAC1 5′UTR F TCTTGTTTCCCTCTGCGTCC 
HDAC1 5′UTR R gcagcaggtctgcattatacTTGAGAAACTGTACGAACCTTCTAGG 
HDAC2 CDS F ggatcaggatcgggtagtATGGTTGTGGAGCCTCCTG 
HDAC2 CDS R TGACTCGTCGTGGAACACAG 
HDAC2 5′UTR F GCTACTGGTGGAGCATGTGT 
HDAC2 5′UTR R gcagcaggtctgcattatacAGCTGGGCATGCAATCAGT 
HDAC3 CDS F ggatcaggatcgggtagtATGGGCAAAGAAACGCGTG 
HDAC3 CDS R TTGCGGTGATGTCCAGAGTG 
HDAC3 5′UTR F CCTGCCATATTGTGGGGGTT 
HDAC3 5′UTR R gcagcaggtctgcattatacTGCGGTTGCGGTTCAAC 
HDAC4 CDS F ggatcaggatcgggtagtATGTCTGTGAGGGAACGG 
HDAC4 CDS R TGACACGTCCGGTAGAAACA 
HDAC4 5′UTR F ATAGACACATCGGCGGAGTT 
HDAC4 5′UTR R gcagcaggtctgcattatacACGATAGAGTTGACTAAGTAAACAC 
Sir2rp1 CDS F ggatcaggatcgggtagtATGACAGAACCGAAGTTAGCAAC 
Sir2rp1 CDS R CATGCCCTTCTTGGCGAGTA 
Sir2rp1 5′UTR F GCTGAAGAGGTGCCTACGTT 




Primer name Sequence 
Sir2rp2 CDS F ggatcaggatcgggtagtATGGCTGACCGCCTTGCT 
Sir2rp2 CDS R CTCGTAGTCGCCATCAGGTC 
Sir2rp2 5′UTR F TGCGCCCATGAGTTGTAGTT 
Sir2rp2 5′UTR R gcagcaggtctgcattatacATCACTCAACTGCACTAGCTTAAAC 
Sir2rp3 CDS F ggatcaggatcgggtagtATGAGGCGGCCCAATGGT 
Sir2rp3 CDS R TCTACGACTCCGCAGCATTC 
Sir2rp3 5′UTR F TGGATGAACCGACTGCACAA 
Sir2rp3 5′UTR R gcagcaggtctgcattatacTGTTGAACCTACAAACAGTCCTTC 
Ago1 CDS F ggatcaggatcgggtagtATGTCTGACTGGGAACGTGG 
Ago1 CDS R GGTTTGTCCATGCCTCCACT 
Ago1 5′UTR F TAGCAGCAAAATGATGGCAC 
Ago1 5′UTR R gcagcaggtctgcattatacTTTATTTAAATCCTTTTTATTAGGTTGC 
KKT2 CDS F ggatcaggatcgggtagtATGTTCAATGTCTCACCAGCG 
KKT2 CDS R CACGTACACTCGACCAAACC 
KKT2 5′UTR F TTACGAGGGGTGGTAGTGGT 
KKT2 5′UTR R gcagcaggtctgcattatacGACTGTGCCCCGTCCCTT 
UP1 CDS F ggatcaggatcgggtagtATGGTAGGAGGATATTTACGTATGC 
UP1 CDS R GTGATCAACAACACATACGGATG 
UP1 5′UTR F TGTCACAGATGGCCCATG 
UP1 5′UTR R gcagcaggtctgcattatacTCCCTATTATGCAATAAAGAGAAAGG 
UP2 CDS F ggatcaggatcgggtagtATGGATTTAGGGGAAGATTCGAC 
UP2 CDS R CTTCCTCGTTACCCACTTGC 
UP2 5′UTR F TCTCCGTTGTTGGCAACC 
UP2 5′UTR R gcagcaggtctgcattatacCACTAATACCTTCTTCACCAGTTAC 
UP3 CDS F ggatcaggatcgggtagtATGAACGAGCCTGATGCCAT 
UP3 CDS R CAAATAGTCAATGAGCACCTGTGG 
UP3 5′UTR F CTGAAGCGTATGGAGACTGGC 




Primer name Sequence 
UP4 CDS F ggatcaggatcgggtagtATGGATCCGGCGGTAGGG 
UP4 CDS R ACAGCAAGCGGGTTCCATG 
UP4 5′UTR F AGTCGTTTAGATGCTTGCGTTG 
UP4 5′UTR R gcagcaggtctgcattatacATGTTGAAGGGAGAAAGTCTACGAT 
JBP2 CDS F ggatcaggatcgggtagtATGCCTATGTTTATGGATGGGGC 
JBP2 CDS R GAAGCCTCTGTGTGAGAGCA 
JBP2 5′UTR F AGGACACACACGAAACCGAT 
















II. Integration validation 
Primer name Sequence 
eYFP F taagcttgtgagcaagggcg 
blast R accatggttagccctccca 
Chromo1 5′UTR F CACCACGGTGCTTGTAGTC 
Chromo1 CDS R GGTACTGAGAGGAAGATTCCTGAA 
PHD12 5′UTR F GGTAAACTATAGCCATTGGGGAC 
PHD12 CDS R AATGTCGCTCGAACCGTTC 
PHD13 5′UTR F GGCAATAGTTTCAGGTGAAGGG 
PHD13 CDS R CAAAGGGTGCTCGATCAGGA 
PWWP1 5′UTR F GTCACACTACTGTAGACCGGTG 
PWWP1 CDS R CTCCTTCCTTGAGATGTGATGACG 
Tudor 5′UTR F CTGCCATATGCCACTCACCT 
Tudor CDS R CGAGATACAGTTTCACAGTCGG 
Znf-CW1 5′UTR F CGCTAAAGTAACCCCTAAGCTC 
Znf-CW1 CDS R GATGAACTGATCACCTCTCCCTC 
BDF2 5′UTR F CTAGTGGATCAACAATTCGAACCC 
BDF2 CDS R CTTGTTCCGTTTTTCTGCACG 
BDF4 5′UTR F CGTTTGTGGGATGATCTTTCCTTAC 
BDF4 CDS R CGCTCCGCTTCTACCTCAG 
SET1 5′UTR F CTCGTAATGGATGCGGACC 
SET1 CDS R CGTGTCCGCCTTAACGAC 
SET2 5′UTR F GATGCTGATCAGCTTTTGGCAC 
SET2 CDS R GCAGCCTGTGTTTCTGGC 
SET3 5′UTR F CGCTTGTTGCTGATGGATG 
SET3 CDS R CCATCGTCATTACCCTCACG 
SET4 5′UTR F CACCACCAACTTGGGGAGG 




Primer name Sequence 
SET5 5′UTR F GAGGAGAGAATGTGTGCGAAG 
SET5 CDS R GAGGTGGGAACACTCAACAG 
SET21 5′UTR F GCCTAGAAGGAAGGCGGTAG 
SET21 CDS R CCAGTTATGTTCACCTTCATCCG 
SET22 5′UTR F GGCAGATGGATGCTTCACCG 
SET22 CDS R GTGCATCCTATCTCCGAGATCG 
SET23 5′UTR F GGCTACTGCAACTGCCATG 
SET23 CDS R GACTATAACAGCCAGCTCCGG 
SET24 5′UTR F CCTGACTGGTCGCTCGTAC 
SET24 CDS R CCGCTGGATTACAACTGTGC 
SET25 5′UTR F GACAGTTGGATTCACTGCACTG 
SET25 CDS R GTCATAAACTTTGCACGACTTATCC 
SET26 5′UTR F GAAGGCATCCCTGCTGCTTC 
SET26 CDS R GCTTTGTTCGTGTTCTTTTGGAG 
SET27 5′UTR F CCTGAGTGGTGTGTGGTAACG 
SET27 CDS R GCACTAATGTTTGCCGTAACG 
SET28 5′UTR F GAACGTTTCCCGTTAGGTCAAAC 
SET28 CDS R CGTAGCAACAGCGGATATGG 
SET29 5′UTR F GAAAGGGGTGCCTACGTGTC 
SET29 CDS R GTCGGGCGCCTCTCTAAC 
SET30 5′UTR F GGTCTCACTGTCAATAAGAGGATG 
SET30 CDS R CGTACCTGATGCACTCAACAG 
Jmj1 5′UTR F CATATGCTTGTTGGTACGACCTTG 
Jmj1 CDS R ATCAGACTGCATGTGCCAGTC 
Jmj2 5′UTR F GAAGCTTGATCTGACTCTCAGGG 
Jmj2 CDS R TGGTGCACATCCATGCCTG 
LCM1 5′UTR F TGGAAGGGATGCACTCCTAG 




Primer name Sequence 
CLD1 5′UTR F TTCAGCCTCTTGGCGCAG 
CLD1 CDS R CTGGTGCCATTCTTACTGTCCT 
HDAC1 5′UTR F GAGGCAACTACTGTTTGCACTC 
HDAC1 CDS R CCGTTTCCAATGCCTACATCC 
HDAC2 5′UTR F GTGGTATGCGTGGATGTAGTTG 
HDAC2 CDS R GCGTAAACTCAAATAGCGCACG 
HDAC3 5′UTR F CGTCGTGACAGTTTTGTGACG 
HDAC3 CDS R CGACACCTGTACCTTCAGCTTC 
HDAC4 5′UTR F GGAAGAGCTCTACCGTGGAG 
HDAC4 CDS R CTCTAGGATCGTATGCCCATGC 
Sir2rp1 5′UTR F TCAACGGCTGGGTGACATC 
Sir2rp1 CDS R GTCTATGTTCTGCGTACAACAGC 
Sir2rp2 5′UTR F GGGCTGGATGACAAATGAGTG 
Sir2rp2 CDS R CCTGCACAACACGGTCAG 
Sir2rp3 5′UTR F GCGGTCTCCACTGCTGTTG 
Sir2rp3 CDS R GCTGCAGGGTATACGTTACCG 
Ago1 5′UTR F GTTGTCTGACTGGAAACTTACTCG 
Ago1 CDS R CCTCGGGTCGATGTACAGAG 
KKT2 5′UTR F GCCTGACCTAATCATTGTCGG 
KKT2 CDS R GACGATACTTTCAAGGCGCAC 
UP1 5′UTR F TGTTCGTGTCGTGGCTGATG 
UP1 CDS R GAGTCTGCTGTATATCCAATGTCC 
UP2 5′UTR F GGTGAAGTGTGAGTACGTGAG 
UP2 CDS R CCATCGTCATCTGGTTTGTGTG 
UP3 5′UTR F CGCCACACACATTATGAAGCG 
UP3 CDS R CCTTTTCTTCTGTAGGTGCACG 
UP4 5′UTR F TGACCGATAATGCATGTTCTGC 




Primer name Sequence 
JBP2 5′UTR F GTGGCGTAATTTGCACAACAAG 


















Clone tests  
All proteins except the ones marked with “PF” were tagged in the bloodstream form. 
I. Protein expression validation 
SET2, SET5, SET21, SET25 and SET30 were not detected by western blot analysis. The 
other candidate proteins were detected in at least some of the clones tested (data below). The 


















II. Tagging constructs integration validation 
The table below summarises the PCR validations carried out to confirm correct construct 
integration at the 5′UTR and CDS junctions of each gene. The number of clones reflects the 
cell line stocks as present on 9 January 2020. Some clones were discarded if they did not 
express the tagged protein or if the PCR validations did not show correct integration. 















Significantly enriched proteins in the affinity purification 
experiments 
 
The cut-offs used for significance are p < 0.01 and log2 (tagged/untagged) > 2 or < -2.  
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